GAMeets - the Instituto Gulbenkian de Ciência - Fundação Calouste ...
GAMeets - the Instituto Gulbenkian de Ciência - Fundação Calouste ...
GAMeets - the Instituto Gulbenkian de Ciência - Fundação Calouste ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
GULBENKIAN ALUMNI MEETINGS<br />
(<strong>GAMeets</strong>)<br />
6th Edition<br />
15th Anniversary of <strong>the</strong> Cúria Meetings<br />
Palace Hotel Cúria<br />
27-28 December 2010<br />
1
Welcome!<br />
This year, we have ma<strong>de</strong> great efforts to bring you all to Curia.<br />
Not only to reminisce of those “gol<strong>de</strong>n” days in <strong>the</strong> past of course,<br />
but most specially to contribute to <strong>the</strong> continuation of our future. We<br />
hope that <strong>the</strong>se two days that we spend toge<strong>the</strong>r will foster many<br />
future collaborations, scientific and o<strong>the</strong>r, thus streng<strong>the</strong>ning our<br />
network as it proliferates through our new entrants, many for whom,<br />
Curia this year is <strong>the</strong> very first time, and to whom we warmly<br />
welcome and hope that this event and this singular location will be<br />
enjoyed in just <strong>the</strong> same manner as it was in <strong>the</strong> past!<br />
Monica Dias, Sofia Araujo and Greta Martins<br />
Some important links for networking:<br />
IGC Facebook<br />
http://www.facebook.com/<strong>Instituto</strong><strong>Gulbenkian</strong>Ciencia<br />
IGC PhD Alumni Facebook Group<br />
http://www.facebook.com/home.php?sk=group_178917335470253<br />
2
MONDAY 27 DECEMBER<br />
Programme<br />
Morning: Arrivals and check-in at <strong>the</strong> Curia Palace Hotel<br />
12h30: Lunch and Opening Session<br />
14h00: SESSION ONE<br />
PGDBM2 - Cláudio Gomes, Margarida Trinda<strong>de</strong>,<br />
Guilherme Neves. PGDB2 - David Cristina, Helena<br />
Soares, Eduardo Silva. PGDB4 - Joana Sá, Paulo<br />
Ribeiro, Tiago Carvalho. PGDBM3 - Pedro Brites,<br />
Perpetua Ó, José Leal. PIBS - Lilia Perfeito, Dinis<br />
Calado, Cristina Borges. PGDBM4 - Alexandra<br />
Capela, Carla Martins. PDBC - Isabel Duarte.<br />
16h30: SESSION TWO: Coffee Break and Poster Session<br />
Mónica Bettencourt-Dias, Sofia Araújo, Ana Teresa<br />
Tavares, Pedro Domingos, Ofélia Carvalho, Francisco<br />
Dionísio, Marta Nunes, Vera Teixeira, Rui Peixoto,<br />
Daniel Sobral, Ulla-Maj Fiuza, Paula Duque, Greta<br />
Martins.<br />
18h00: SESSION THREE<br />
PGDB1 - Vanessa Zuzarte, Miguel Gaspar, Luís<br />
Soares. PGDB5 - Ana Mateus, Ricardo Silva, Catia<br />
Proença. PGDB3 - César Evaristo, José Antão,<br />
Catarina Homem. PGDBM5 - Bruno Silva-Santos, Rita<br />
Nunes, Susana Nery, Isabel Gordo. PGDMB6 - Rita<br />
Teodoro, Luis Teixeira. PGDBM7 - Tiago Carneiro, Mª<br />
João Leão<br />
20h30: Dinner<br />
3
22h00: Jonathan Howard,<br />
TUESDAY 28 DECEMBER<br />
University of Cologne, Germany and IGC SAB Member<br />
“How to build a perfect institute”<br />
9h30-10h40: SESSION FOUR<br />
PGDBM1- António Jacinto, Luís Martins, José Belo,<br />
Isabel Palmeirim, PGFMA-Ana Cer<strong>de</strong>ira, Sofia Braga,<br />
INDP-Maria Inês Vicente, Pedro Ferreira.<br />
10h45-11h00: Coffee break<br />
11h00-12h00: Maria Leptin, Director, EMBO, Germany<br />
“My Life in Science”<br />
12h00-12h30: Closing Session:<br />
António Coutinho, IGC and Diogo Lucena, FCG<br />
13h00: Lunch – Leitão at Anadia Museum<br />
4
ABSTRACTS FOR ORAL PRESENTATIONS<br />
Monday 27 December<br />
SESSION ONE<br />
6
Protein <strong>de</strong>position pathways at <strong>the</strong> synaptic milieu<br />
Claudio M. Gomes<br />
<strong>Instituto</strong> <strong>de</strong> Tecnologia Química e Biológica, Universida<strong>de</strong> Nova <strong>de</strong><br />
Lisboa, Oeiras<br />
My laboratory investigates <strong>the</strong> biology and biophysics of protein<br />
folding, <strong>the</strong> essential cellular process through which proteins acquire<br />
a functional conformation. In recent years we have addressed how<br />
this process is affected in neuro<strong>de</strong>generative and metabolic diseases,<br />
resulting in protein misfolding or aggregation (1-3). Protein<br />
<strong>de</strong>position as amyloid oligomers in <strong>the</strong> human nervous system is<br />
characteristic of neuro<strong>de</strong>generative diseases such as Alzheimer’s and<br />
Parkinson’s. The i<strong>de</strong>ntification of cellular modulators of protein<br />
<strong>de</strong>position remains a challenging issue, which has been <strong>the</strong> focus of<br />
our recent attention.<br />
In this brief talk I will overview our approach to un<strong>de</strong>rstand <strong>the</strong><br />
biology and mechanisms of protein aggregation in <strong>the</strong> nervous<br />
system. In particular I will focus on <strong>the</strong> role played by <strong>the</strong> unique<br />
chemical biology of <strong>the</strong> synaptic environment, namely high<br />
concentrations of metal ions and secreted proteins in a molecular and<br />
physically confined environment. To illustrate this aspect I will<br />
overview our recent progresses on <strong>the</strong> analysis of amyloid formation<br />
by S100 proteins, which are upregulated in <strong>the</strong> brain in amyloid<br />
diseases (Alzheimer’s and ALS), and <strong>the</strong> cross talk with <strong>the</strong> amyloidbeta<br />
pepti<strong>de</strong> un<strong>de</strong>r conditions mimicking <strong>the</strong> synaptic environment<br />
(4).<br />
1. Kim, S., Leal, S. S., Ben Halevy, D., Gomes, C. M., and Lev, S.<br />
(2010) J Biol Chem 285(18), 13839-13849<br />
2. Henriques, B. J., Rodrigues, J. V., Olsen, R. K., Bross, P., and<br />
Gomes, C. M. (2009) J Biol Chem 284(7), 4222-4229<br />
3. Correia, A. R., Adinolfi, S., Pastore, A., and Gomes, C. M. (2006)<br />
Biochem J 398(3), 605-611<br />
4. Fritz, G., Botelho, H. M., Morozova Roche, L., and Gomes, C. M.<br />
(2010) FEBS J, in press<br />
8
Science is funding<br />
Margarida Trinda<strong>de</strong><br />
<strong>Instituto</strong> <strong>de</strong> Medicina Molecular, Faculda<strong>de</strong> <strong>de</strong> Medicina da<br />
Universida<strong>de</strong> <strong>de</strong> Lisboa<br />
Margarida Trinda<strong>de</strong> is currently responsible for Science Funding, at<br />
<strong>the</strong> Communication and Training Unit at <strong>the</strong> <strong>Instituto</strong> <strong>de</strong> Medicina<br />
Molecular (IMM) in Lisbon. Her current responsibilities inclu<strong>de</strong><br />
supporting researchers assembling national and international<br />
research funding proposals, grant application management, contract<br />
negotiation and training on grant writing for graduate stu<strong>de</strong>nts. At<br />
<strong>the</strong> interface of <strong>the</strong> Institute’s administrative services and <strong>the</strong><br />
researchers, Margarida’s goal is to foster an environment for<br />
additional science funding at IMM.<br />
9
TRANSGENIC MICE<br />
Guilherme Neves (1) Mala Shah (2) Petros Liodis (1) and Vassilis<br />
Pachnis (1)<br />
(1) Molecular Neurobiology Division, NIMR, London, UK<br />
(2) The School of Pharmacy, UCL, London, UK<br />
Defects in inhibitory circuits in <strong>the</strong> cortex often un<strong>de</strong>rpin <strong>the</strong> emersion<br />
of seizure activity. However <strong>the</strong> relative importance of somatic versus<br />
<strong>de</strong>ndritic inhibition in <strong>the</strong> pathogenesis of epilepsy remains unclear.<br />
The LIM homeodomain transcription factor Lhx6 is essential for <strong>the</strong><br />
differentiation of <strong>the</strong> parvalbumin (Pva) and somatostatin (Sst)<br />
expressing subpopulations of GABAergic interneurons, and for <strong>the</strong><br />
normal <strong>de</strong>velopment of inhibitory circuits in <strong>the</strong> mouse cortex. Null<br />
mutations in Lhx6 result in a pronounced <strong>de</strong>ficit in synaptic inhibition<br />
and anatomical signs of severe seizure activity. Interestingly,<br />
hypomorphic Lhx6 mutants show a remarkably selective <strong>de</strong>ficit in <strong>the</strong><br />
differentiation of Sst+ interneurons. Moreover, <strong>the</strong>se animals show<br />
behavioural, histological and electroencephalographic signs of<br />
recurrent seizure activity, starting from early adulthood. Consistent<br />
with a selective <strong>de</strong>fect in <strong>the</strong> differentiation of Sst+ interneurons,<br />
which project primarily to <strong>the</strong> <strong>de</strong>ndritic compartment of principal<br />
neurons, we have observed characteristic <strong>de</strong>ficits in <strong>de</strong>ndritic<br />
inhibition but normal inhibitory input onto <strong>the</strong> somatic compartment<br />
of pyramidal cells. These data implicate <strong>the</strong> Sst+ interneuron<br />
population as an important control system that normally prevents <strong>the</strong><br />
emergence of seizure activity.<br />
10
Technology Transfer in <strong>the</strong> Greater Lisbon Area<br />
David Cristina, Bruno Reynolds, Lígia Martins and António Coutinho<br />
IGC, ITQB<br />
Technology Transfer (TT) is <strong>the</strong> exploitation, commercial or<br />
o<strong>the</strong>rwise, of scientific research for <strong>the</strong> direct benefit of society. It's<br />
activities inclu<strong>de</strong> sourcing invention disclosures, guaranteeing patent<br />
protection, licensing technologies, forming spin-out companies and<br />
managing consultancy opportunities for scientists. The quality of<br />
Portuguese Life Sciences research has increased significantly over <strong>the</strong><br />
last 10 years, however <strong>the</strong> TT structures have not kept up with this<br />
<strong>de</strong>velopment. As part of our project, we are <strong>de</strong>veloping a TT Office<br />
addressing this specific need for <strong>the</strong> Greater Lisbon area. We are<br />
doing this by analyzing different international TT mo<strong>de</strong>ls and<br />
adjusting <strong>the</strong>m to <strong>the</strong> national context. We have already started<br />
providing services to researchers and, so far, we have been able to<br />
assist in <strong>the</strong> formation of a "start-up", Acellera Therapeutics.<br />
11
Hierarchically regulated exocytosis controls signal amplification at <strong>the</strong><br />
immunological synapse and is targeted by HIV-1<br />
Helena Martins Soares (1) Françoise Porrot (2) Olivier Schwartz (2)<br />
Maria-Isabel Thoulouze (1) and Andrés Alcover (1)<br />
(1) Lymphocyte Cell Biology Unit<br />
(2) Virus an Immunity Unit. Institut Pasteur<br />
T cell receptor (TCR) signaling is triggered and controlled at<br />
immunological synapses. TCR and signaling effectors concentrate at<br />
<strong>the</strong> synapse, form dynamic signaling clusters, being <strong>the</strong>n differentially<br />
sorted. This facilitates <strong>the</strong> induction, amplification and extinction of<br />
TCR signaling that drives T cell activation. Intracellular vesicle<br />
transport targets <strong>the</strong> TCR, <strong>the</strong> tyrosine kinase Lck and <strong>the</strong> adaptor<br />
LAT to <strong>the</strong> synapse, but <strong>the</strong> regulation of this transport and its<br />
significance for TCR signaling remain unknown. We show that HIV-1<br />
dissects this vesicle transport unveiling that Lck, TCR and LAT are in<br />
distinct vesicular compartments that concomitantly polarize to <strong>the</strong><br />
synapse. Lck compartment fuses first with <strong>the</strong> plasma membrane in a<br />
calcium-in<strong>de</strong>pen<strong>de</strong>nt manner, <strong>the</strong>n regulating <strong>the</strong> calcium-<strong>de</strong>pen<strong>de</strong>nt<br />
fusion of TCR and LAT compartments, and <strong>the</strong> subsequent LAT<br />
phosphorylation. Therefore, a hierarchically regulated exocytocitic<br />
process drives signal amplification at <strong>the</strong> immunological synapse.<br />
HIV-1 breaks this process by retaining Lck in endosomes <strong>the</strong>refore<br />
uncoupling LAT from <strong>the</strong> TCR.<br />
12
Material Systems for targeting and reversing ischemia<br />
Eduardo A. Silva<br />
Wyss Institute for Biologically Inspired Engineering - Harvard<br />
University<br />
Spatially and temporally regulated signaling between and within cell<br />
populations and <strong>the</strong> extracellular matrix regulate tissue homeostasis,<br />
pathology and regeneration, and polymeric materials that can mimic<br />
or enhance this communication have <strong>the</strong> potential to intervene in<br />
<strong>the</strong>se processes in a <strong>the</strong>rapeutic manner. These cell instructive<br />
polymer systems provi<strong>de</strong> insoluble signaling molecules and cues<br />
(e.g., adhesion pepti<strong>de</strong>s) or soluble signaling molecules (e.g., growth<br />
factors) alone or in specific combinations to ei<strong>the</strong>r host tissue cells or<br />
to transplanted cells to regulate <strong>the</strong>ir activation, multiplication and<br />
differentiation. Multiple aspects of regeneration must be consi<strong>de</strong>red to<br />
<strong>de</strong>sign effective approaches to enable functional tissue replacement,<br />
and this issue has been addressed in <strong>the</strong> context of angiogenesis. The<br />
systems <strong>de</strong>scribed in this research could represents an attractive new<br />
generation of <strong>the</strong>rapeutic <strong>de</strong>livery vehicle for treatment of<br />
cardiovascular diseases, as it combines long term in vivo <strong>the</strong>rapeutic<br />
benefit with minimally invasive <strong>de</strong>livery.<br />
13
Dead mules: when strong post-zygotic isolation is not sufficient to<br />
prevent mating<br />
Joana Gonçalves-Sá (1,2,3) and Andrew Murray (1,2)<br />
(1) MCB, Harvard University, Cambridge, MA 02138, USA<br />
(2) FAS Center for Systems Biology, Harvard University, Cambridge,<br />
MA 02138, USA<br />
(3) <strong>Gulbenkian</strong> Ph.D. Program in Biomedicine, IGC, Oeiras, Portugal<br />
Speciation, <strong>the</strong> paradigm has it, happens when two populations can<br />
no longer interbreed and give rise to fertile progeny. Thus, <strong>the</strong><br />
prediction is that if two species share an ecological niche and <strong>the</strong>ir<br />
hybrids have very strong fitness <strong>de</strong>fects, <strong>the</strong>re would be an<br />
advantage in evolving mechanisms to prevent mating events between<br />
<strong>the</strong>m.<br />
In Saccharomyces cerevisiae mating occurs when two haploid cells of<br />
opposite mating types fuse. The two cells communicate through<br />
secreted pheromones and <strong>the</strong> corresponding transmembrane<br />
receptors and we asked whe<strong>the</strong>r, like in o<strong>the</strong>r species, receptor<br />
specificity could be playing a role in reproductive isolation.<br />
We looked at <strong>the</strong> evolution of <strong>the</strong> specificity of <strong>the</strong> pepti<strong>de</strong> receptor<br />
Ste2 in <strong>the</strong> phylum Ascomycota. We i<strong>de</strong>ntified Ste2-like receptors<br />
from different species and expressed a subset of <strong>the</strong>m in S.<br />
cerevisiae. Thirteen of <strong>the</strong> heterologously expressed receptors<br />
successfully respon<strong>de</strong>d to self-pheromone and some of <strong>the</strong>m are<br />
surprisingly promiscuous and can respond to high concentrations of<br />
pheromones from different species. We see no evi<strong>de</strong>nce of positive<br />
selection in <strong>the</strong> pheromone receptors contrasting with previous<br />
studies of genes involved in speciation, and this can explain <strong>the</strong><br />
cross-talk between different receptors and pheromones.<br />
We tested whe<strong>the</strong>r this lack of specificity could be enough to allow<br />
<strong>de</strong>tection, recognition and mating. We crossed two sympatric species,<br />
S. cerevisiae and S. castellii and observed that <strong>the</strong>y can fuse at high<br />
frequency but no viable diploids are formed in <strong>the</strong> process.<br />
We conclu<strong>de</strong> that in <strong>the</strong> Saccharomyces, speciation is most likely not<br />
happening at <strong>the</strong> receptor/pheromone recognition level and that, in<br />
<strong>the</strong>se species, strong post-zygotic isolation is not sufficient to prevent<br />
mating.<br />
14
Regulation of tissue growth in Drosophila<br />
Paulo S. Ribeiro<br />
Postdoctoral Fellow<br />
Tapon Lab - Apoptosis and Proliferation Control Laboratory<br />
Cancer Research UK, London Research Institute<br />
44 Lincoln’s Inn Fields<br />
London WC2A 3LY<br />
United Kingdom<br />
Metazoan organ <strong>de</strong>velopment requires strict control of cell<br />
proliferation, growth and <strong>de</strong>ath. Studies in Drosophila have i<strong>de</strong>ntified<br />
a novel signalling pathway, <strong>the</strong> Hippo (Hpo) pathway, which is<br />
required for tissue size control as it inhibits proliferation and<br />
promotes apoptosis. Since many of <strong>the</strong> pathways that limit tissue size<br />
during <strong>de</strong>velopment also function in adults, <strong>the</strong>y are often <strong>the</strong> targets<br />
of cancer-causing alterations. Hpo pathway members are highly<br />
conserved and, <strong>de</strong>pending on <strong>the</strong>ir function, can act as tumour<br />
suppressors or oncogenes in mammals.<br />
The Hpo pathway consists of a kinase casca<strong>de</strong> comprising <strong>the</strong> kinases<br />
Hpo and Warts (Wts), which culminates in <strong>the</strong> inhibition of Yorkie<br />
(Yki), a growth-promoting transcriptional co-activator involved in<br />
tumourigenesis. Hpo signalling is also regulated by upstream<br />
members, such as <strong>the</strong> atypical cadherin Fat, <strong>the</strong> cytoskeletal band<br />
4.1 proteins Expan<strong>de</strong>d (Ex) and Merlin (Mer), and <strong>the</strong> newly i<strong>de</strong>ntified<br />
Kibra. Moreover, <strong>the</strong> kinase adaptor proteins Mats, Salvador (Sav)<br />
and dRASSF can also control <strong>the</strong> activity of <strong>the</strong> pathway. Although<br />
some of <strong>the</strong> major pathway components are known, <strong>the</strong> molecular<br />
mechanisms regulating Hpo signalling activity are still unclear. In<br />
particular, little is known about <strong>the</strong> negative regulation of <strong>the</strong> kinase<br />
casca<strong>de</strong> that lies at <strong>the</strong> core of <strong>the</strong> Hpo pathway.<br />
Using Drosophila as a mo<strong>de</strong>l system, we have recently characterised<br />
<strong>the</strong> in vivo and molecular functions of a PP2A phosphatase complex<br />
that negatively regulates Hpo signalling, which was i<strong>de</strong>ntified using<br />
combined high-throughput genomic and proteomic approaches.<br />
We will discuss <strong>the</strong>se new findings and <strong>the</strong> future of Hpo pathway<br />
research.<br />
15
Laboratory Or<strong>de</strong>rs: how to enjoy 2 extra weeks of vacation<br />
Tiago P. Carvalho<br />
PetriDish Software Lda.<br />
After completing his PhD in 2009, Tiago <strong>de</strong>ci<strong>de</strong>d to return to Portugal<br />
to start "something" <strong>the</strong>re. That "something" is now PetriDish<br />
Software Lda., a software company located at <strong>the</strong> Science and<br />
Technology Park of <strong>the</strong> University of Porto (UPTEC).<br />
The name of <strong>the</strong> company is homage to Julius Richard Petri, who<br />
invented <strong>the</strong> Petri dishes, while he was working as a research<br />
assistant in <strong>the</strong> laboratory of <strong>the</strong> not-less-famous Robert Koch. Petri<br />
dishes are a simple but brilliant invention, and <strong>the</strong>ir quick adoption<br />
ma<strong>de</strong> some laboratory practices so straightforward that today one<br />
rarely thinks about <strong>the</strong> difficulties that existed before Petri dishes<br />
were invented.<br />
Similarly, PetriDish Software is <strong>de</strong>voted to <strong>the</strong> <strong>de</strong>velopment and<br />
implementation of simple but smart software solutions. We humbly<br />
aim at making a Scientist\'s life so much easier, to <strong>the</strong> point that one<br />
day no one will un<strong>de</strong>rstand how it would be possible to work without<br />
some of our software solutions.<br />
Or<strong>de</strong>ring laboratory products or reagents is perceived by <strong>the</strong><br />
Scientific community as an annoying and time-consuming process.<br />
Our first product is <strong>the</strong> LabOr<strong>de</strong>rs online platform, which makes that<br />
process easier, faster, cheaper and more efficient (at<br />
http://www.labor<strong>de</strong>rs.com).<br />
In this talk I will present LabOr<strong>de</strong>rs live, while sharing <strong>the</strong> UPs and<br />
DOWNs of starting a company in Portugal<br />
16
The obscurity of plasmalogens in <strong>the</strong> spotlight<br />
Pedro Brites<br />
Nerve Regeneration Group, <strong>Instituto</strong> <strong>de</strong> Biologia Molecular e Celular,<br />
Porto, Portugal<br />
The importance of peroxisomes for normal function and physiology is<br />
highlighted by <strong>the</strong> severe disease sate, with severe pathology and<br />
poor outcome of patients with a disor<strong>de</strong>r caused by impaired<br />
peroxisomal function. Peroxisomes perform a myriad of functions that<br />
inclu<strong>de</strong> beta-oxidation of very-long-chain fatty acids, alpha-oxidation<br />
of phytanic acid, <strong>de</strong>gradation of hydrogen peroxi<strong>de</strong>, and <strong>the</strong><br />
biosyn<strong>the</strong>sis of plasmalogens (PLS).<br />
The peroxisomal disor<strong>de</strong>r, rhizomelic chondrodysplasia punctata<br />
(RCDP) is caused by <strong>the</strong> impairment in <strong>the</strong> biosyn<strong>the</strong>sis of PLS and is<br />
characterized by <strong>de</strong>fects in bone, eye and nervous tissue. PLS are<br />
e<strong>the</strong>r-phospholipids characterized by a vinyl-e<strong>the</strong>r bond at <strong>the</strong> sn-1<br />
position of <strong>the</strong> glycerol backbone. Despite an unclear physiologic<br />
function, PLS function as (i) <strong>de</strong>terminants of membrane structure and<br />
fluidity, (ii) pools of polyunsaturated fatty acids and (iii) scavengers<br />
of oxidative damage. Using mouse knockout mo<strong>de</strong>ls <strong>de</strong>ficient in PLS<br />
we aim at un<strong>de</strong>rstanding human disor<strong>de</strong>rs, characterize <strong>the</strong> <strong>de</strong>fects<br />
caused by a PLS <strong>de</strong>ficiency and <strong>de</strong>termine <strong>the</strong> mechanism and<br />
players involved in pathology caused by PLS <strong>de</strong>ficiency. Since<br />
nervous tissue is extremely rich in PLS we set out to characterize and<br />
<strong>de</strong>termine <strong>the</strong> role of PLS in neurons and in myelin. Our analysis<br />
revealed that in neurons a <strong>de</strong>ficiency in PLS causes abnormalities in<br />
<strong>the</strong> structure and patterning of neuromuscular junctions.<br />
A <strong>de</strong>ficiency in PLS also leads to abnormalities in myelin and in<br />
myelination characterized by <strong>de</strong>compaction of myelin sheaths and<br />
impaired myelination during <strong>de</strong>velopment, and after a lesion. Our<br />
results indicate that PLS are important structural components of<br />
membranes and that <strong>the</strong>ir <strong>de</strong>ficiency affects multiple processes. Due<br />
to <strong>the</strong>ir role in membranes, PLS may also modulate <strong>the</strong> disease state<br />
of non-peroxisomal disor<strong>de</strong>rs.<br />
17
At <strong>the</strong> Heart of INEB's Stem Cell Biology Team<br />
D.S. Nascimento, A. Freire, M. Valente and P.Pinto-do-Ó<br />
NEWTherapies Group, INEB - <strong>Instituto</strong> <strong>de</strong> Engenharia Biomédica,<br />
Universida<strong>de</strong> do Porto, Porto, Portugal<br />
Our team focus is on elucidating how stem/progenitor cells (SC)<br />
engage in regeneration and repair in adult-tissues. Special emphasis<br />
is placed on <strong>the</strong> mechanisms involved in <strong>the</strong> regulation of <strong>the</strong> socalled<br />
SC niches. Currently, <strong>the</strong> working paradigm is that of <strong>the</strong> heart<br />
as an organ endowed with endogenous cardiac stem/progenitor cell<br />
(CSC/CPC) population(s) and thus with self-regenerating potential.<br />
Myocardium-resi<strong>de</strong>nt putative CPCs display hallmarks of stemness<br />
and <strong>the</strong>ir antigenic profile, i.e. Sca+/c-Kit+/MDR1+, by matching that<br />
of o<strong>the</strong>r adult SC, raises <strong>the</strong> question as to whe<strong>the</strong>r CPCs originate in<br />
<strong>the</strong> heart or are continuously replenished from o<strong>the</strong>r organs. We<br />
address <strong>the</strong>se issues in an integrative manner. An experimental<br />
mouse-mo<strong>de</strong>l of myocardial infarction (MI) was established and a<br />
thorough cellular/molecular analysis of specific CPC-subsets is<br />
un<strong>de</strong>rway. Aiming at <strong>the</strong> i<strong>de</strong>ntification of molecules involved in CPCs<br />
stress-response signaling pathway(s), a series of transcripts have<br />
been serially evaluated in <strong>the</strong> Sca-1+ CPCs isolated from nonmanipulated,<br />
sham-operated and mice subjected to MI. At <strong>the</strong> tissuelevel,<br />
and to portray <strong>the</strong> CPCs, <strong>the</strong>ir differentiating progeny and<br />
supporting cells at <strong>the</strong> natural niche, protocols/tools for optimal in<br />
situ analysis have been a subject of continuous investment. Thus,<br />
from <strong>the</strong> digging and drawing of <strong>the</strong> cardiac stem/progenitor cells<br />
response(s) to heart injury a draft of (i) <strong>the</strong> kinetics of <strong>the</strong> cardiacniche’s<br />
composition and of (ii) <strong>the</strong> molecular blueprint of <strong>the</strong> CPC<br />
response to MI starts to emerge.<br />
18
From evolution to <strong>the</strong> bed-si<strong>de</strong><br />
Jose B. Pereira-Leal<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong> – Portugal<br />
Whe<strong>the</strong>r translational research should go from mechanistic cellular<br />
and molecular studies to its application, i.e. bench to <strong>the</strong> bed-si<strong>de</strong>, or<br />
from <strong>the</strong> clinical problem and human samples to <strong>the</strong> basic laboratory,<br />
i.e. bed-si<strong>de</strong> to <strong>the</strong> bench, is an issue that polarizes <strong>the</strong> biomedical<br />
community. I will discuss an example of a less explored translational<br />
avenue - from evolutionary studies to <strong>the</strong> bed-si<strong>de</strong>. In <strong>the</strong><br />
Computational Genomics Laboratory (evocell.org) of <strong>the</strong> Institute<br />
<strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong> we are broadly interested in <strong>the</strong> evolutionary<br />
cell biology of cellular compartmentalization or modularity. We aim to<br />
un<strong>de</strong>rstand <strong>the</strong> evolutionary mechanisms by which cellular processes<br />
are physically separated, focusing on intracellular organelles. While<br />
studying <strong>the</strong> origin of bacterial-<strong>de</strong>rived organelles (e.g. mitochondria,<br />
chloroplasts, etc) we investigated <strong>the</strong> drivers of gene loss in<br />
intracellular parasites. We discovered that in addition to well-known<br />
drivers, e.g. no need for biosyn<strong>the</strong>tic pathways, <strong>the</strong>re is extensive<br />
loss of genetic redundancy.<br />
From an evolutionary perspective, our results support <strong>the</strong> notion that<br />
environmental predictability is a major driver of genome evolution.<br />
From a translational perspective, this discovery un<strong>de</strong>rpinned a new<br />
approach to drug repositioning, i.e. finding new uses for existing<br />
drugs, that already uncovered a new type of antibiotic. I will also<br />
discuss how o<strong>the</strong>r “evolutionary” projects in <strong>the</strong> lab are leading us to<br />
a translational context.<br />
19
Fitness Landscape of a Metabolic Pathway<br />
Lilia Perfeito (1,2) Stephane Ghozzi (2) Johannes Berg (2) Karin<br />
Schnetz (1) and Michael Laessig (2)<br />
(1) Institut für Genetik, Universitat zu Köln, Zälpicherstrasse 47a,<br />
50674 Cologne, Germany<br />
(2) Institut für Theoretische Physik, Universitat zu Köln,<br />
Zälpicherstrasse 77, 50937 Cologne, Germany<br />
In or<strong>de</strong>r to un<strong>de</strong>rstand how new functions evolve, it is important to<br />
know which phenotypes and un<strong>de</strong>r selection and how mutations<br />
affect <strong>the</strong>m. In this work, I show how this approach can be used to<br />
address <strong>the</strong> problem of <strong>the</strong> evolution of gene regulation. Genes are<br />
regulated because <strong>the</strong>ir expression involves a fitness cost to <strong>the</strong><br />
organism. The production of proteins by transcription and translation<br />
is a well-known cost factor, but <strong>the</strong> enzymatic activity of <strong>the</strong> proteins<br />
produced can also reduce fitness. We mapped <strong>the</strong> fitness costs of a<br />
key metabolic network, <strong>the</strong> lactose utilization pathway in Escherichia<br />
coli. We measured <strong>the</strong> growth of several regulatory lac operon<br />
mutants in different environments inducing expression of <strong>the</strong> lac<br />
genes. We find a strikingly nonlinear fitness landscape, which<br />
<strong>de</strong>pends on <strong>the</strong> production rate and on <strong>the</strong> activity rate of <strong>the</strong> lac<br />
proteins.<br />
A simple fitness mo<strong>de</strong>l of <strong>the</strong> lac pathway, based on elementary<br />
biophysical processes, predicts <strong>the</strong> growth rate of all observed<br />
strains. The nonlinearity of fitness is explained by a feedback loop:<br />
production and activity of <strong>the</strong> lac proteins reduce growth, but growth<br />
itself reduces <strong>the</strong> <strong>de</strong>nsity of <strong>the</strong>se molecules through dilution. This<br />
nonlinearity has important consequences for pathway function and<br />
evolution. It generates an activation threshold of <strong>the</strong> lac operon,<br />
above which bacterial growth abruptly drops to low values.<br />
Fur<strong>the</strong>rmore, <strong>the</strong> nonlinearity <strong>de</strong>termines how <strong>the</strong> fitness of operon<br />
mutants <strong>de</strong>pends on <strong>the</strong> inducer environment. Fitness nonlinearities,<br />
growth thresholds, and gene-environment interactions are likely<br />
generic features of metabolic pathways and have implications for <strong>the</strong><br />
evolution of regulation.<br />
20
NFκB signaling cooperates with cMyc to induce B cell transformation<br />
and multiple myeloma in <strong>the</strong> mouse<br />
Calado DP (1) Zhang B (1) Sasaki Y (2) Wun<strong>de</strong>rlich T (3)<br />
Schmidt Supprian M (4) and Rajewsky K (1)<br />
(1) PCMM/Immune Disease Institute, Harvard Medical School, Boston,<br />
USA<br />
(2) RIKEN Center for Developmental Biology, Kobe, Japan<br />
(3) The Institute of Genetics of <strong>the</strong> University of Cologne, Cologne,<br />
Germany<br />
(4) Max Planck Institute of Biochemistry, Munich, Germany<br />
Constitutive NFκB signaling and <strong>de</strong>regulation of cMyc expression are<br />
recurrent events in <strong>the</strong> ABC subgroup of Diffuse Large B cell<br />
Lymphoma (ABC/DLBCL), and in Multiple Myeloma (MM). However, it<br />
remains to be <strong>de</strong>termined whe<strong>the</strong>r constitutive NFκB signaling and<br />
<strong>de</strong>regulated cMyc expression, cooperate to induce B cell<br />
transformation and consequently are at <strong>the</strong> origin of ABC/DLBCL and<br />
or MM. To test this hypo<strong>the</strong>sis we used conditional targeted<br />
mutagenesis in <strong>the</strong> mouse, to express a constitutively active IKK2<br />
molecule and/or cMyc in CD19pos B cells through tamoxifen induced<br />
Cre mediated elimination of a STOP cassette. The genetic system of<br />
conditional targeted mutagenesis used in this work is unique in two<br />
ways. First, transgene activation occurs only in a small fraction of<br />
CD19pos B cells (3 to 5%) through transient Cre expression,<br />
mimicking <strong>the</strong> sporadic nature of oncogenic events. Second, due to<br />
incomplete Cre mediated recombination in individual cells, this<br />
CD19+ B cell population is constituted by IKK2capos/MYCpos,<br />
IKK2capos/MYCneg and IKK2caneg/MYCpos expressing cells,<br />
providing all possible “oncogene” combinations in <strong>the</strong> same mouse at<br />
<strong>the</strong> same time.<br />
We observed that 100% of <strong>the</strong> mice succumbed to a plasma cell<br />
neoplasia <strong>de</strong>rived from <strong>the</strong> IKK2capos/MYCpos population, with a<br />
median survival of 192 days. Thus, using a conditional targeted<br />
mutagenesis system that recapitulates <strong>the</strong> sporadic nature of<br />
oncogenic events, we <strong>de</strong>monstrate that constitutive NFκB signaling<br />
cooperates with <strong>de</strong>regulated cMyc expression to induce B cell<br />
transformation and MM in <strong>the</strong> mouse. These results suggest that this<br />
oncogene combination represents a primary event in MM ra<strong>the</strong>r than<br />
ABC/DLBCL.<br />
21
Tight Junction components: novel players in Epi<strong>the</strong>lial<br />
Morphogenesis?<br />
Ana Cristina Borges (1,2) Ana Cristina Silva (1,2) Jorge Carneiro<br />
(1) Mathias Koeppen (1) and António Jacinto (1,2)<br />
(1) <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> Ciencia<br />
(2) <strong>Instituto</strong> <strong>de</strong> Medicina Molecular<br />
We are interested in <strong>the</strong> un<strong>de</strong>rstanding of <strong>the</strong> molecular mechanisms<br />
involved in <strong>the</strong> sealing of an epi<strong>the</strong>lial discontinuity that occur both in<br />
normal <strong>de</strong>velopment and eventually during tissue repair. We are<br />
using <strong>the</strong> zebrafish embryo as a mo<strong>de</strong>l system, since it allows <strong>the</strong><br />
study of <strong>the</strong> morphogenetic movements of epiboly and wound<br />
healing. In both cases, closure of <strong>the</strong> gap is achieved as <strong>the</strong> opposing<br />
tissue margins move toward each o<strong>the</strong>r to un<strong>de</strong>rgo fusion. Tissue<br />
movement is driven by coordinated changes in cellular morphology,<br />
which require mechanical force. How is such force generated in a<br />
moving sheet of cells? A common feature observed both in normal<br />
morphogenesis and wounds is <strong>the</strong> formation of a supracellular<br />
actin/myosin cable which contracts and closes <strong>the</strong> gap in a purse<br />
string-like fashion.<br />
Currently, we are investigating <strong>the</strong> role of Tight Junctions (TJ) in<br />
<strong>the</strong>se processes. Our preliminary results revealed that <strong>the</strong> TJ protein<br />
tjp-3/ZO-3 is required for <strong>the</strong> formation of <strong>the</strong> actin/myosin cable.<br />
The impairment in cable formation leads to a <strong>de</strong>lay of <strong>the</strong> epiboly<br />
process and to a failure in wound closure. These observations<br />
implicate TJ components as novel players in epi<strong>the</strong>lial morphogenesis.<br />
22
How to preserve vision? Path to clinical application using human<br />
neural stem cells<br />
Alexandra Capela<br />
StemCells Inc.<br />
Age-related macular <strong>de</strong>generation (AMD) and retinitis pigmentosa<br />
(RP) are <strong>the</strong> two most prominent human retinal <strong>de</strong>generative<br />
disor<strong>de</strong>rs and combined account for <strong>the</strong> majority of vision loss in<br />
people over 40 years old.<br />
StemCells Inc. has <strong>de</strong>veloped a purified population of human central<br />
nervous system stem cells (hCNS-SCns) that are currently being<br />
tested in 3 clinical studies, Neuronal Ceroid Lipofuscinosis, a<br />
lysosomal storage disor<strong>de</strong>r, Pelizaeus-Merzbacher Disease, a<br />
dysmyelination disor<strong>de</strong>r and Spinal Cord injury. We now <strong>de</strong>monstrate<br />
that hCNS-SCns transplanted into <strong>the</strong> subretinal space of <strong>the</strong> Royal<br />
College of Surgeons (RCS) rat mo<strong>de</strong>l, a well-characterized animal<br />
mo<strong>de</strong>l of progressive photoreceptor <strong>de</strong>generation, rescue<br />
photoreceptors from <strong>de</strong>generation and preserve visual acuity and<br />
visual field sensitivity. These findings support clinical evaluation of<br />
hCNS-SCns as a neuroprotective strategy for select retinal<br />
<strong>de</strong>generative disor<strong>de</strong>rs.<br />
23
p53-targeted tumor <strong>the</strong>rapy: potential and limitations<br />
Melissa R. Junttila, Daniel Garcia, Anthony N. Karnezis, Francesc<br />
Madriles, Gerard I. Evan and Carla P. Martins(*)<br />
University of California San Francisco, Department of Pathology and<br />
Helen Diller Family Comprehensive Cancer Center, San Francisco,<br />
California 94143-0502, USA<br />
(*) Present address: Cancer Research UK Cambridge Research<br />
Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 ORE, UK<br />
The high prevalence of specific mutations in tumors ma<strong>de</strong> targeted<br />
<strong>the</strong>rapies a new priority in drug <strong>de</strong>velopment. Inactivation of <strong>the</strong> p53<br />
pathway is a common feature in human tumors fostering <strong>the</strong><br />
attractive notion that p53-function restoration would constitute an<br />
effective and tumor-specific <strong>the</strong>rapeutic strategy. To establish <strong>the</strong><br />
<strong>the</strong>rapeutic potential of this approach we mo<strong>de</strong>led in vivo <strong>the</strong> impact<br />
of p53 restoration in tumors. We recently showed that p53<br />
restoration triggers dramatic tumor regression in a murine lymphoma<br />
mo<strong>de</strong>l, highlighting <strong>the</strong> <strong>the</strong>rapeutic potential of this strategy. To<br />
<strong>de</strong>termine its impact in epi<strong>the</strong>lial tumors we carried out a<br />
comprehensive analysis of <strong>the</strong> timing and mechanisms of p53<br />
activation during <strong>the</strong> evolution of lung tumors, <strong>the</strong> leading cause of<br />
cancer-related <strong>de</strong>ath worldwi<strong>de</strong>. Using a murine mo<strong>de</strong>l of non-small<br />
cell lung carcinoma we show that unexpectedly, p53 restoration failed<br />
to induce lung tumor clearance. Never<strong>the</strong>less we show that p53<br />
efficiently targets <strong>the</strong> most malignant tumor cells, but allows for <strong>the</strong><br />
less aggressive cell populations to survive. This tumor stage specific<br />
activation of p53 results from a selective increase in oncogenic<br />
signaling in malignant cells. The failure of low-level oncogenic stress<br />
to engage p53 reveals inherent limits in <strong>the</strong> capacity of p53 to<br />
restrain early tumor evolution and in <strong>the</strong> efficacy of <strong>the</strong>rapeutic p53<br />
restoration to eradicate cancers. Strategies aimed at improving <strong>the</strong><br />
<strong>the</strong>rapeutic impact of targeted <strong>the</strong>rapies for lung cancer treatment<br />
will also be discussed.<br />
24
The remarkable functional divergence of <strong>the</strong> Eukaryotic organellar<br />
Release Factors<br />
Isabel Duarte, Ramiro Morgado and Martijn Huynen<br />
ID and MH are affiliated with CMBI - NCMLS, Radboud University,<br />
Nijmegen, The Ne<strong>the</strong>rlands; RM is affiliated with Computational and<br />
Systems Biology - JIC, Norwich, UK<br />
Motivation: Organellar gene expression is far from un<strong>de</strong>rstood, with<br />
<strong>the</strong> genetic co<strong>de</strong> of <strong>the</strong> human mitochondrion being elucidated only in<br />
2010.<br />
Two codon-specific RFs are sufficient for <strong>de</strong> facto organellar<br />
translation termination: RF1 and RF2, but at least 3 o<strong>the</strong>r different<br />
subfamilies have been <strong>de</strong>scribed, whose exact function remains<br />
elusive. Our <strong>de</strong>tailed analysis sought to integrate different sources of<br />
information: localization prediction and experimental data available,<br />
phylogenetic distribution, organellar genetic co<strong>de</strong> and sequence<br />
structural features, to better <strong>de</strong>scribe this superfamily and predict<br />
unannotated proteins function.<br />
Materials and Methods: We used comparative genomics (Sequence<br />
Homology Searches, Multiple Sequence Alignment and Phylogeny)<br />
and Protein Structure Prediction to study <strong>the</strong> organellar RF<br />
superfamily in a carefully selected group of representative Eukaryotic<br />
organisms.<br />
Results and Discussion: This study briefly reports a new plant specific<br />
release factor subfamily, which has lost <strong>the</strong> 3 functional motifs<br />
experimentally <strong>de</strong>scribed as essential for bona-fi<strong>de</strong> release factor<br />
activity. Also, it predicts a plant RF2 subfamily, to be chloroplastic<br />
and not mitochondrial as previously annotated. And finally, we<br />
propose a possible re-invention of <strong>the</strong> standard genetic co<strong>de</strong> in <strong>the</strong><br />
green algae lineage.<br />
Conclusion: Here we analyze <strong>the</strong> evolution of organellar ribosomal<br />
Release Factors, uncovering a remarkable functional differentiation<br />
and showing its co-evolution with <strong>the</strong> organellar genetic co<strong>de</strong>. Also,<br />
our studies confirm <strong>the</strong> previously published evolutionary origin for<br />
<strong>the</strong> mitochondrial and plastidial RFs, in accordance with <strong>the</strong> currently<br />
undisputed endosymbiotic origin of <strong>the</strong>se organella. Finally, <strong>the</strong> motif<br />
shuffling and loss seen on each RF subfamily, hints at a significant<br />
functional divergence, hence proving that much is still to be<br />
uncovered about this process!<br />
25
ABSTRACTS FOR POSTER PRESENTATIONS<br />
Monday 27 December<br />
SESSION TWO<br />
26
Centrosome & Cilia Biogenesis & Evolution<br />
Mónica Bettencourt-Dias<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />
Our research focuses on cell cycle progression and <strong>the</strong> cytoskeleton in<br />
normal <strong>de</strong>velopment and disease. We are particularly interested in<br />
<strong>the</strong> role played by microtubule organizing structures, such as <strong>the</strong><br />
centrosome, cilia and flagella. The centrosome is <strong>the</strong> major<br />
microtubule organizer in animal cells, and is very often abnormal in<br />
cancer. Cilia and flagella are cellular projections which are<br />
indispensable in a variety of cellular and <strong>de</strong>velopmental processes<br />
including cell motility, propagation of morphogenic signals and<br />
sensory reception. Despite <strong>the</strong>ir importance, we know very little<br />
about centrosome and cilia biogenesis or how <strong>the</strong>y may go awry in<br />
human disease. Our laboratory uses an integrated approach to study<br />
those questions: we combine studies in mo<strong>de</strong>l organisms with studies<br />
in human cells and bioinformatics to have an integrated view of this<br />
process. The fruit fly is an excellent organism to address those<br />
questions, since it combines possibilities of screening<br />
multiple genes with <strong>the</strong> ability to perform in-<strong>de</strong>pth regulation studies<br />
in <strong>the</strong> whole organism. As <strong>the</strong> regulatory mechanisms of <strong>the</strong> cell cycle<br />
and cytoskeleton have been highly conserved throughout evolution,<br />
we can extrapolate our findings to humans to test <strong>the</strong>ir relevance for<br />
human disease. An un<strong>de</strong>rstanding of <strong>the</strong> pathways involved in cell<br />
cycle and cytoskeleton can generate diagnostic and prognostic<br />
markers and hopefully provi<strong>de</strong> novel <strong>the</strong>rapeutic targets in human<br />
disease.<br />
28
Shared mechanisms during neural <strong>de</strong>velopment and tubulogenesis<br />
Sofia J. Araújo<br />
IBMB-CSIC, IRB Barcelona, Spain<br />
Tissue and organ morphogenesis in multicellular organisms relies on<br />
<strong>the</strong> precise coordination of multiple molecular pathways that control<br />
distinct cellular events. Cellular migration and pathfinding are two<br />
processes essential for morphogenesis. Their precise temporal and<br />
spatial coordination is crucial for cells to be able to establish<br />
connections over long distances. Correct control allows <strong>de</strong>velopment<br />
of multicelular organisms. Defects in control are associated with<br />
cancer <strong>de</strong>velopment.<br />
In Drosophila melanogaster neural and tracheal morphogenesis both<br />
involve cellular migration and pathfinding. To date, studies of<br />
Drosophila’s nervous and tracheal <strong>de</strong>velopment have been often<br />
performed separately, <strong>de</strong>spite <strong>the</strong> many common features between<br />
<strong>the</strong> two systems. This overlap is suggestive of shared mechanisms<br />
and cellular cooperation are likely to exist. We have been<br />
investigating <strong>the</strong> cooperative influence of tracheal cell migration and<br />
axonal guidance during <strong>de</strong>velopment. We have analysed a genetic<br />
screen for which mutants were isolated and characterised by <strong>the</strong>ir<br />
nervous system phenotypes and investigated <strong>the</strong>ir tracheal<br />
phenotypes. This approach is allowing us to i<strong>de</strong>ntify novel factors<br />
involved in <strong>the</strong> <strong>de</strong>velopment of both systems.<br />
29
Characterization and applications of a novel hemangioblast-specific<br />
transcriptional enhancer<br />
Ana Teresa Tavares (1,2) Vera Teixeira (2) and António Duarte<br />
(1,2)<br />
(1) CIISA, FMV, Lisboa, Portugal<br />
(2) IGC, Oeiras, Portugal<br />
During early vertebrate embryogenesis, <strong>the</strong>re is a close<br />
<strong>de</strong>velopmental relation between hematopoiesis and vasculogenesis.<br />
Primitive hematopoietic and endo<strong>the</strong>lial lineages both <strong>de</strong>rive from<br />
aggregates of meso<strong>de</strong>rmal cells that form <strong>the</strong> blood islands in <strong>the</strong><br />
extraembryonic yolk sac. This observation has led to <strong>the</strong> hypo<strong>the</strong>sis<br />
that both cell types originate from a common precursor known as <strong>the</strong><br />
hemangioblast. Chick Cerberus gene (cCer) co<strong>de</strong>s for a secreted<br />
factor expressed in <strong>the</strong> anterior mesendo<strong>de</strong>rm that gives rise to blood<br />
islands, among o<strong>the</strong>r tissues.<br />
During <strong>the</strong> study of cCer transcriptional regulation in chick embryos,<br />
we isolated a short cis-regulatory region that is able to drive reporter<br />
gene expression specifically in blood island precursor cells or<br />
hemangioblasts. We have been using this hemangioblast-specific<br />
reporter construct (Hb-eGFP) to characterize <strong>the</strong> gene expression<br />
profile of <strong>the</strong> chick hemangioblast and to track <strong>the</strong> origin and fate of<br />
hemangioblasts in living embryos. Here, we will present data on <strong>the</strong><br />
cell type-specificity of <strong>the</strong> hemangioblast enhancer as well as on <strong>the</strong><br />
dynamics of blood island morphogenesis and differentiation observed<br />
in Hb-eGFP-electroporated chick embryos.<br />
30
A genetic screen to i<strong>de</strong>ntify genes mediating ER stress induced retinal<br />
<strong>de</strong>generation in Drosophila<br />
Vanya Rasheva, Nadine Schweizer and Pedro Domingos<br />
<strong>Instituto</strong> <strong>de</strong> Tecnologia Química e Biológica (ITQB), Universida<strong>de</strong><br />
Nova <strong>de</strong> Lisboa, Av. Republica (EAN), 2780-157, Oeiras, Portugal<br />
(domingp@itqb.unl.pt)<br />
The endoplasmic reticulum (ER) is <strong>the</strong> cell organelle where secretory<br />
and membrane proteins are syn<strong>the</strong>sized and fol<strong>de</strong>d. Proteins that fail<br />
to fold properly (misfol<strong>de</strong>d proteins) accumulate in <strong>the</strong> ER, causing<br />
ER stress. The Unfol<strong>de</strong>d Protein Response (UPR) consists of several<br />
signalling pathways that have evolved to <strong>de</strong>tect <strong>the</strong> accumulation of<br />
misfol<strong>de</strong>d proteins in <strong>the</strong> ER and activate a cellular response that<br />
attempts to maintain homeostasis in <strong>the</strong> ER. If <strong>the</strong> protective<br />
mechanisms activated by <strong>the</strong> UPR are not sufficient to restore normal<br />
ER function cells die by apoptosis. How is <strong>the</strong> UPR regulated to<br />
change from a protective response to a pro-apoptotic one is still<br />
un<strong>de</strong>r question.<br />
We are performing a mosaic genetic screen aimed at i<strong>de</strong>ntifying<br />
suppressors of <strong>the</strong> retinal <strong>de</strong>generation phenotype caused by Xbp1<br />
overexpression in <strong>the</strong> eye. The i<strong>de</strong>ntification of genes regulated by<br />
Xbp1 will allow <strong>the</strong> characterization of <strong>the</strong> protective and apoptotic<br />
signalling pathways induced by ER stress.<br />
31
WDR62 in microcephaly and assymetric brain <strong>de</strong>velopment<br />
Ofelia P. <strong>de</strong> Carvalho, A<strong>de</strong>line K. Nicolas, Maryam Khurshid and C.<br />
Geoffrey Woods<br />
Cambridge Institute for Medical Research, University of Cambridge<br />
Autosomal recessive primary microcephaly (MCPH) is a disor<strong>de</strong>r of<br />
neuro<strong>de</strong>velopment resulting in a small brain. We i<strong>de</strong>ntified<br />
homozygous and frame-shifting <strong>de</strong>letions of WDR62 in seven<br />
consanguineous MCPH families. As well as being involved in MCPH,<br />
WDR62 mutations have been i<strong>de</strong>ntified in families with a wi<strong>de</strong><br />
spectrum of brain <strong>de</strong>velopment abnormalities including but not<br />
exclusive of microcephaly.<br />
In human cell lines WDR62 localizes to <strong>the</strong> spindle pole during<br />
mitosis, and in both mouse and human embryonic brain expression is<br />
found in neural precursors during mitosis. We attempt to elucidate<br />
<strong>the</strong> <strong>de</strong>velopmental mechanism(s) perturbed by mutations in this<br />
gene.<br />
32
Mutualistic Parasites - when hosts make use of <strong>the</strong>ir parasites and<br />
pathogens<br />
Francisco Dionisio<br />
Centro <strong>de</strong> Biologia Ambiental da Faculda<strong>de</strong> <strong>de</strong> Ciencias da<br />
universida<strong>de</strong> <strong>de</strong> Lisboa & <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> Ciencia<br />
Parasites or pathogens and <strong>the</strong>ir hosts are expected to have<br />
conflicting interests, simply because parasite reproduction and<br />
transmission is done at <strong>the</strong> expense of <strong>the</strong> hosts fitness. However,<br />
this may not always be <strong>the</strong> case. Infected hosts can use <strong>the</strong>ir<br />
parasites/pathogens to harm o<strong>the</strong>rs, and increase <strong>the</strong>ir own relative<br />
fitness.<br />
33
The impact of antiretroviral treatment on <strong>the</strong> bur<strong>de</strong>n of invasive<br />
pneumococcal disease in South African children: A time series<br />
analysis<br />
Marta C Nunes, Shabir A and Madhi<br />
Respiratory and Meningeal Pathogens Research Unit, Department of<br />
Science and Technology/National Research Foundation: Vaccine<br />
Preventable Diseases, University of <strong>the</strong> Witwatersrand, South Africa<br />
Objective: HIV infection is a major risk factor for invasive<br />
pneumococcal disease (IPD). A national antiretroviral program was<br />
initiated in South Africa in 2004. This study evaluates <strong>the</strong> impact of<br />
<strong>the</strong> highly active antiretroviral (HAART) treatment program on <strong>the</strong><br />
bur<strong>de</strong>n of IPD among African children.<br />
Design: Retrospective analysis of laboratory-confirmed IPD among<br />
children un<strong>de</strong>r 18 years of age, from 2003 to 2008.<br />
Methods: The periods 2003-2004, 2005-2006 and 2007-2008 were<br />
<strong>de</strong>fined as <strong>the</strong> early-, intermediate- and established-HAART eras,<br />
respectively.<br />
Pneumococcal conjugate vaccine was not introduced into public<br />
immunization during this period.<br />
Results: 1,171 episo<strong>de</strong>s of IPD were i<strong>de</strong>ntified over <strong>the</strong> study-period.<br />
Among HIV-infected children un<strong>de</strong>r 18 years, <strong>the</strong> bur<strong>de</strong>n of IPD<br />
<strong>de</strong>creased by 50.8% (95% CI: 41.5; 58.7) and <strong>the</strong> inci<strong>de</strong>nce of IPDrelated<br />
mortality <strong>de</strong>clined by 65.2% (95% CI: 47.2; 77.0) from <strong>the</strong><br />
early- compared to <strong>the</strong> established-HAART era. This <strong>de</strong>cline in HIVinfected<br />
children was evi<strong>de</strong>nt for pneumococcal bacteremia and<br />
pneumococcal meningitis. In addition, similar reductions were<br />
observed for serotypes inclu<strong>de</strong>d in a 7-valent pneumococcal<br />
conjugate vaccine and non-vaccine serotypes. The bur<strong>de</strong>n of IPD<br />
remained unchanged in HIV-uninfected children un<strong>de</strong>r 18 years of<br />
age over <strong>the</strong>se periods. The risk of IPD, however, remained 42-fold<br />
greater in HIV-infected compared to HIV-uninfected children in <strong>the</strong><br />
established-HAART era.<br />
Conclusions: Although <strong>the</strong> HAART program has been associated with<br />
significant <strong>de</strong>clines in IPD morbidity and mortality, HIV-infected<br />
African children with access to HAART remain a high-risk group for<br />
IPD. These children should <strong>the</strong>refore be prioritized in <strong>the</strong> prevention<br />
of IPD.<br />
34
Role of Dll4-Notch signaling pathway in <strong>the</strong> angiogenesis of<br />
a<strong>the</strong>rosclerotic lesions and its potential <strong>the</strong>rapeutic aplication<br />
Vera Teixeira (1,2) Joana Gigante (1,2) Dusan Djokovic (1,2) and<br />
Ana Tavares (1,2)<br />
(1) CIISA, Faculda<strong>de</strong> <strong>de</strong> Medicina Veterinaria, Lisboa<br />
(2) <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> Ciencia, Oeiras, Portugal<br />
A<strong>the</strong>rosclerosis is a <strong>de</strong>generative disease characterized by vascular<br />
inflammation, endo<strong>the</strong>lial dysfunction and progressive formation of<br />
intima plaques composed of lipids, calcium, and cellular <strong>de</strong>bris. As<br />
plaque <strong>de</strong>velops, new vessels arising from <strong>the</strong> adventitial vasa<br />
vasorum grow into <strong>the</strong> media and intima lesions. Evi<strong>de</strong>nces implicate<br />
<strong>the</strong>se neovessels in <strong>the</strong> regulation of plaque growth and stability.<br />
A<strong>the</strong>roma neovascularization inhibition has been proposed as an<br />
approach to restrict plaque growth and promote stabilization. In<strong>de</strong>ed,<br />
a promising antiangiogenic strategy for a<strong>the</strong>rosclerosis would<br />
<strong>de</strong>crease neovessel proliferation and induce functional maturation of<br />
<strong>the</strong> plaque microvessels. However, preliminary observations showing<br />
Dll4 expression increased in a<strong>the</strong>roma suggest also <strong>the</strong>rapeutical<br />
benefit in Dll4/Notch-inhibition. Therefore, we will investigate Dll4<br />
expression pattern during plaque <strong>de</strong>velopment, vasa vasorum levels<br />
in ApoE-/- mice and human patients, function of Dll4 in plaque<br />
angiogenesis and <strong>the</strong> <strong>the</strong>rapeutic potential of Dll4/Notch signaling<br />
modulators in <strong>the</strong> prevention and/or treatment of a<strong>the</strong>rosclerosis.<br />
Taken our current knowledge on <strong>the</strong> function of Dll4 in physiological<br />
and tumor angiogenesis we expect modulation of Dll4 levels to be an<br />
effective treatment of a<strong>the</strong>rosclerotic lesions. Our findings will<br />
contribute to unravel <strong>the</strong> molecular mechanisms of a<strong>the</strong>roma<br />
angiogenesis.<br />
35
Activity Depen<strong>de</strong>nt Cleavage of Neuroligin-1<br />
Rui Peixoto, Portia McCoy, Ben Philpot and Michael Ehlers<br />
Duke University, University of North Carolina<br />
Adhesive contact between pre- and postsynaptic neurons initiates<br />
synapse formation during brain <strong>de</strong>velopment and provi<strong>de</strong>s a natural<br />
means of trans-synaptic signaling. Numerous adhesion molecules and<br />
<strong>the</strong>ir role during synapse <strong>de</strong>velopment have been <strong>de</strong>scribed in <strong>de</strong>tail.<br />
However, once established, <strong>the</strong> mechanisms of adhesive disassembly<br />
and its function in regulating synaptic transmission have been<br />
uncertain. Here, we report that synaptic activity induces acute<br />
proteolytic cleavage of neuroligin-1 (NLG1), a postsynaptic adhesion<br />
molecule at glutamatergic synapses. NLG1 cleavage is triggered by<br />
NMDA receptor activation, requires Ca2+/calmodulin-<strong>de</strong>pen<strong>de</strong>nt<br />
protein kinase, and is mediated by proteolytic activity of matrix<br />
metalloprotease 9 (MMP9). Cleavage of NLG1 occurs in vivo, is<br />
regulated over brain <strong>de</strong>velopment, and causes rapid <strong>de</strong>stabilization of<br />
its presynaptic partner neurexin-1β (NRX1β). In turn, NLG1<br />
cleavage rapidly <strong>de</strong>presses synaptic transmission by abruptly<br />
reducing presynaptic release probability. Toge<strong>the</strong>r, our results <strong>de</strong>fine<br />
a novel mechanism for synapse remo<strong>de</strong>ling and trans-synaptic<br />
signaling during brain <strong>de</strong>velopment and plasticity.<br />
36
Ensembl Regulation: Functional Genomics @ Ensembl<br />
N. Johnson, D. Sobral, D. Keefe, B. Pritchard, S. Wil<strong>de</strong>r, E. Birney, P.<br />
Flicek and I. Dunham<br />
European Bioinformatics Institute (EMBL-EBI), Wellcome Trust<br />
Genome Campus, Hinxton, Cambridge, UK<br />
The Ensembl Functional Genomics (eFG) database and Application<br />
Program Interface (API) provi<strong>de</strong>s a platform for storage, analysis and<br />
visualisation of functional genomics data, within <strong>the</strong> centralised family<br />
of EnsEMBL databases. Wi<strong>de</strong>spread uptake of Nexte Generation<br />
Sequencing (NGS) based methods in projects including HEROIC,<br />
ENCODE and <strong>the</strong> Epigenomics Roadmap, as well as smaller<br />
hypo<strong>the</strong>sis-driven projects, has initiated a flood of data on<br />
transcription factor (TF) binding and chromatin state. The eFG<br />
databases incorporate 285 data sets from <strong>the</strong>se projects, primarily<br />
from ChIP-seq and DNase-seq assays across 9 human and 4 murine<br />
cell lines. This inclu<strong>de</strong>s <strong>the</strong> genomic binding sites for 56 TFs as well<br />
as <strong>the</strong> locations for 40 histones modifications. An additional 23 data<br />
sets i<strong>de</strong>ntifying sites of open chromatin or DNase 1 hypersensitivity<br />
are also now available. Data is incorporated via a standardised read<br />
mapping and peak calling pipeline to generate both normalised<br />
signal data and predicted enriched regions (“peaks” or “hits”) with<br />
peak summits. Both signal data and enriched regions are ma<strong>de</strong><br />
available in <strong>the</strong> Ensembl browser for visual comparison and<br />
interrogation.<br />
Higher-level annotations are also available in eFG, in <strong>the</strong> form of<br />
‘Regulatory Features’. The ‘Regulatory Build’ process uses all TF and<br />
open chromatin data across all cell types to establish locations that<br />
are potentially active in regulation (regulatory cores) in a multi-cell<br />
build step. Each cell-specific core region is <strong>the</strong>n exten<strong>de</strong>d, given that<br />
appropriate supporting data (e.g. histone markers) is present in that<br />
cell type. Regulatory Features are <strong>the</strong>n classified by consi<strong>de</strong>ring how<br />
different patterns of attributes are distributed in relation to various<br />
genomic features (e.g. promoter-associated, gene-associated). This<br />
process gives a set of annotated Regulatory Features for each cell<br />
type, as well as a set of core Regulatory Features presented in a<br />
multi-cell track.<br />
Ensembl is committed to immediate release of data and analysis into<br />
<strong>the</strong> public domain. As with all Ensembl software, eFG is available<br />
un<strong>de</strong>r an open source license from www.ensembl.org.<br />
37
Notch signalling regulation by cis-inhibitory effects<br />
Ulla-Maj Fiuza, Isabelle Becam,Thomas Klein, Marco Milán and<br />
Alfonso Martinez Arias<br />
Department of Genetics (University of Cambridge)<br />
Institute for Research and Biomedicine (Barcelona)<br />
Institute for Genetics (University of Cologne)<br />
Notch signalling is used iteratively during <strong>de</strong>velopment and also in<br />
<strong>the</strong> adult organism. There are several known diseases related with<br />
miss-regulation of <strong>the</strong> signalling activity, many causing severe<br />
<strong>de</strong>fects and some fatal. Un<strong>de</strong>rstanding <strong>the</strong> mechanisms involved in<br />
<strong>the</strong> regulation of this signalling pathway is of great importance for<br />
addressing how to tackle Notch related pathologies. In this work we<br />
present a study on <strong>the</strong> mechanisms of Notch signalling regulation<br />
mediated by interactions between <strong>the</strong> Notch receptor and its ligands<br />
Delta and Serrate. We start by fur<strong>the</strong>r characterizing a well<br />
established observation that Notch ligands besi<strong>de</strong>s having an<br />
activating role can have an inhibitory activity in a concentration<br />
<strong>de</strong>pen<strong>de</strong>nt manner. This function of ligands has been many times<br />
ascribed in <strong>the</strong> literature as a cell autonomous effect but no formal<br />
evi<strong>de</strong>nce for this had been previously produced. We fur<strong>the</strong>r present in<br />
vivo evi<strong>de</strong>nce suggesting that <strong>the</strong> Notch region involved in this<br />
inhibitory interaction is <strong>the</strong> Notch EGF-repeats 10-12 domain and cell<br />
culture data indicating that <strong>the</strong> ligand-inhibitory effect results from<br />
high levels of ligand inhibiting <strong>the</strong> ectodomain shedding of Notch.<br />
Ano<strong>the</strong>r type of inhibitory interactions is also explored that Notch can<br />
have a cis-inhibitory activity on Serrate signalling ability. The<br />
mechanism behind this regulatory interaction is i<strong>de</strong>ntified as an<br />
inhibitory regulation by Notch of <strong>the</strong> levels of Serrate. These crossregulatory<br />
interactions have paramount importance in establishing<br />
<strong>the</strong> state of signalling activity in different biological contexts for<br />
example: ligand cis-inhibition has been seen to modulate stem cell<br />
maintenance in epi<strong>the</strong>lial tissues and <strong>the</strong>re are now evi<strong>de</strong>nces<br />
towards evolution leading to protein specialization with some Delta<br />
family molecules only having an inhibitory activity. It will be<br />
interesting to see how this regulatory mechanisms act in multiple<br />
biological contexts.<br />
38
The SR45 plant-specific splicing factor is a negative regulator of sugar<br />
signaling during early growth in Arabidopsis<br />
Raquel Carvalho, Sofia Carvalho and Paula Duque<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, Oeiras, Portugal<br />
Being sessile, plants have <strong>de</strong>veloped unique adaptive strategies to<br />
cope with abiotic stress. These range from morphological<br />
modifications to physiological responses at <strong>the</strong> cellular level, but <strong>the</strong><br />
basis of <strong>the</strong> capacity for adaptation lies ultimately at <strong>the</strong> level of <strong>the</strong><br />
genome. Many plant genes un<strong>de</strong>rgo alternative splicing, which<br />
increases transcriptome and proteome complexity likely to be crucial<br />
in plant tolerance to adverse environmental conditions.<br />
Serine/arginine-rich (SR) proteins are known to modulate alternative<br />
splicing and o<strong>the</strong>r aspects of RNA metabolism, but <strong>the</strong>ir potential role<br />
in plant stress responses remains unexplored. Using reverse genetics,<br />
we found that SR45, a plant-specific Arabidopsis SR protein highly<br />
conserved throughout <strong>the</strong> plant kingdom with no orthologs in<br />
animals, is a novel player in glucose signaling during early seedling<br />
<strong>de</strong>velopment.<br />
The sr45-1 mutation confers hypersensitivity to glucose, with mutant<br />
seedlings grown in <strong>the</strong> presence of <strong>the</strong> sugar displaying impaired<br />
cotyledon <strong>de</strong>velopment and hypocotyl elongation, as well as altered<br />
glucose-responsive gene expression. The mo<strong>de</strong> of action of SR45<br />
involves downregulation of <strong>the</strong> abscisic acid (ABA) stress signaling<br />
pathway, via repression of both glucose-induced ABA endogenous<br />
accumulation and ABA biosyn<strong>the</strong>sis and signaling gene expression.<br />
Epistasis analyses suggest a mechanism in<strong>de</strong>pen<strong>de</strong>nt of <strong>the</strong><br />
hexokinase 1 (HXK1) sugar sensor, and preliminary results indicate<br />
that SR45 modulates <strong>the</strong> levels of KIN10, a protein kinase involved in<br />
sensing/signaling of stress-associated energy <strong>de</strong>privation.<br />
39
When knowledge is <strong>the</strong> product – what is customer value?<br />
A study of market orientation in a research not-for-profit<br />
organisation.<br />
Greta Martins<br />
MBA dissertation <strong>the</strong>sis, University of Leicester, UK<br />
The rationale of market orientation (MO) is based on Porter (1985)’s<br />
five-competitive force mo<strong>de</strong>l for industries in <strong>the</strong> creation of value by<br />
raising entrance barriers through engen<strong>de</strong>ring and sustaining<br />
competitive advantage. The marketing philosophy holds that a way to<br />
do this is by satisfying customer needs and wants more effectively<br />
than competitors. MO is conceptualised on profitability maximisation<br />
through <strong>de</strong>livering superior customer value to competitors by<br />
harnessing resources on an organisation-wi<strong>de</strong> basis, hence literature<br />
advocates <strong>the</strong> existence of an MO culture in an organisation.<br />
Rapidly changing environments have forced not-for-profits (NFP)s to<br />
adopt businesses practices such as MO for sustainability and growth.<br />
In<strong>de</strong>ed studies show that NFPs favour stronger links with<br />
organisational performance than businesses in <strong>de</strong>veloping an MO<br />
strategy. However, studies reveal that due to <strong>the</strong> higher social<br />
context of <strong>the</strong> NFP environment, as opposed to mandatory initiatives,<br />
it is more effective to adopt market activities into <strong>the</strong> culture so as to<br />
<strong>de</strong>velop a market orientation culture. This study takes a counter<br />
view that when a NFP is knowledge-based, MO is <strong>de</strong>veloped through<br />
organisational culture. Therefore <strong>the</strong> nature of <strong>the</strong> NFP activity<br />
influences <strong>the</strong> <strong>de</strong>velopment of MO.<br />
A small NFP scientific research institution (<strong>the</strong> <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong><br />
<strong>Ciência</strong>) was selected as empirical context. Semi-structured<br />
interviews were conducted to gain insight into <strong>the</strong> <strong>de</strong>velopment of MO<br />
through <strong>the</strong> relationship of <strong>the</strong> scientists with a key stakehol<strong>de</strong>r<br />
group – <strong>the</strong> PhD stu<strong>de</strong>nts. In consi<strong>de</strong>ring <strong>the</strong> stu<strong>de</strong>nts as customers<br />
what were <strong>the</strong> perceptions of customer value?<br />
40
ABSTRACTS FOR ORAL PRESENTATIONS<br />
Monday 27 December<br />
SESSION THREE<br />
42
Host response mechanisms to malaria liver infection: The role of<br />
ubiquitin-proteasome pathway<br />
Zuzarte-Luís (1) N. Nagaraj (2) C. Carret (1) M. Mann (2) and M.<br />
Mota (1)<br />
(1) <strong>Instituto</strong> <strong>de</strong> Medicina Molecular, Portugal<br />
(2) Max Planck Institute for Biochemistry, Martinsried, Germany<br />
Malaria is caused by Plasmodium, an apicomplexan parasite<br />
transmitted through <strong>the</strong> bite of an infected female Anopheles<br />
mosquito. The infection starts when <strong>the</strong> mosquito injects Plasmodium<br />
sporozoites into <strong>the</strong> skin of <strong>the</strong> vertebrate host. After traversing <strong>the</strong><br />
<strong>de</strong>rmis <strong>the</strong> parasites enter <strong>the</strong> circulatory system and travel to <strong>the</strong><br />
liver where <strong>the</strong>y un<strong>de</strong>rgo major transformations and commence a<br />
period of remarkable schizogynous division into an exoerythrocytic<br />
form (EEF). This asymptomatic <strong>de</strong>velopment step will eventually lead<br />
to <strong>the</strong> release of thousands of mature merozoites into <strong>the</strong><br />
bloodstream, initiating <strong>the</strong> symptomatic stage of <strong>the</strong> disease.<br />
In humans, <strong>the</strong> hepatic stage of <strong>the</strong> infection lasts 6-10 days during<br />
which <strong>the</strong> number of parasites expands enormously, up to 40000<br />
fold. Surprisingly, such an active process of parasitic <strong>de</strong>velopment<br />
progresses “invisible” to <strong>the</strong> host’s immune system. As a<br />
consequence, immunity to <strong>the</strong> hepatic stage is not acquired naturally<br />
and hence, populations in malaria en<strong>de</strong>mic areas lack protective<br />
immunity, even after repeated exposures to <strong>the</strong> parasite.<br />
Un<strong>de</strong>rstanding how <strong>the</strong> <strong>de</strong>veloping parasite overcomes <strong>the</strong> host<br />
immune system guaranteeing its own survival will constitute a major<br />
breakthrough, possibly leading to <strong>the</strong> <strong>de</strong>velopment of an anti-malarial<br />
vaccine.<br />
44
Herpesviral Intrahost Spread<br />
Miguel Gaspar and Philip Stevenson<br />
University of Cambridge<br />
Herpesviruses are important human pathogens able to establish a<br />
life-long latent infection insi<strong>de</strong> host cells hid<strong>de</strong>n from <strong>the</strong> immune<br />
system. Murid Herpesvirus 4 (MuHV4) is a gamma-herpesvirus that<br />
infects mice and is commonly used as an in vivo mo<strong>de</strong>l of <strong>the</strong> human<br />
gamma-herpesviruses EBV and KSHV as <strong>the</strong> characteristics of <strong>the</strong>ir<br />
infections are similar. MuHV4 enters <strong>the</strong> organism via <strong>the</strong> nose,<br />
probably infecting an epi<strong>the</strong>lial cell, and establishes latency insi<strong>de</strong> B<br />
lymphocytes in <strong>the</strong> lymph no<strong>de</strong>s and spleen. However, it is unknown<br />
how <strong>the</strong> virus reaches <strong>the</strong> lymph no<strong>de</strong>s and spleen and how it infects<br />
its main cellular target, B cells as <strong>the</strong>se cells are resistant to infection<br />
in vitro. We are currently testing <strong>the</strong> hypo<strong>the</strong>sis that MuHV4 uses<br />
<strong>de</strong>ndritic cells (DCs) as Trojan horses to reach <strong>the</strong> lymph no<strong>de</strong>s and<br />
to infect B cells by cell-to-cell transmission. We have already show<br />
that DCs are susceptible to MuHV4 infection in vivo and in vitro and<br />
that latent in vitro infection results in a dramatic rearrangement of<br />
<strong>the</strong> actin cytoskeleton and o<strong>the</strong>r structural changes associated with<br />
increased mobility.<br />
We are currently using mice expressing Cre recombinase in DCs in<br />
combination with viruses where loxP sites flank essential genes and<br />
fluorescent markers in or<strong>de</strong>r to <strong>de</strong>monstrate <strong>the</strong> importance of DCs in<br />
virus dissemination insi<strong>de</strong> <strong>the</strong> host. The i<strong>de</strong>ntification of a specific cell<br />
type responsible for <strong>the</strong> transport of <strong>the</strong> virus from <strong>the</strong> site of lytic<br />
replication to <strong>the</strong> site of latency can yield novel <strong>the</strong>rapeutic targets to<br />
prevent latency establishment.<br />
45
Coupling RNA processing and chromatin modification in S.cerevisiae<br />
Luis Soares and Steve Buratowski<br />
BCMP, Harvard Medical School, Boston MA<br />
Eukaryotic gene expression inclu<strong>de</strong>s several steps that must be<br />
coordinated to allow organisms to survive, <strong>de</strong>velop and adapt to<br />
environmental changes. The first step in gene expression involves <strong>the</strong><br />
transcription of genes with <strong>the</strong> production of mRNAs that are later<br />
translated into proteins. Between <strong>the</strong> initial and final events of gene<br />
expression <strong>the</strong> mRNA un<strong>de</strong>rgoes several processing steps that affect<br />
its ability to be translated.<br />
It has been shown that transcription and RNA processing are not<br />
temporarily separated and must be connected in or<strong>de</strong>r to achieve<br />
correct gene expression. Pre-mRNA processing events such as<br />
splicing and poly-a<strong>de</strong>nylation have been shown to be <strong>de</strong>pen<strong>de</strong>nt on<br />
<strong>the</strong> modulation of <strong>the</strong> activity of RNA polymerase II and on <strong>the</strong><br />
modifications of <strong>the</strong> CTD of its largest subunit.<br />
Using S.cerevisiae as a mo<strong>de</strong>l system we study <strong>the</strong> recruitment of<br />
processing factors to transcribing genes and how this recruitment<br />
correlates with chromatin modifications. Our results revealed that<br />
modulation of particular histone modifications in yeast affect RNA<br />
processing efficiency by modifying <strong>the</strong> cotrancriptional recruitment of<br />
factors. We i<strong>de</strong>ntified a novel pathway by which <strong>the</strong> COMPASS<br />
complex (responsible for H3K4 methylation) affects <strong>the</strong> recruitment<br />
of splicing and poly-a<strong>de</strong>nylation factors during transcription. The<br />
mechanism of this effect seems to be <strong>de</strong>pen<strong>de</strong>nt both on <strong>the</strong> direct<br />
recruitment of factors by this complex and on general effects that<br />
H3K4 methylation has on <strong>the</strong> activity of RNA polymerase II.<br />
46
Patterned cell-adhesion during morphogenesis<br />
Ana Mateus and Alfonso Martinez Arias<br />
Affiliations for Abstract - Department of Genetics, Cambridge<br />
University, UK<br />
Cell shape changes within epi<strong>the</strong>lia require <strong>the</strong> regulation of adhesive<br />
molecules that maintain tissue integrity. How remo<strong>de</strong>lling of cell<br />
contacts and maintenance of tissue integrity is achieved is a<br />
fundamental question in morphogenesis. Cadherins are<br />
transmembrane proteins that mediate cell-cell adhesion and, in<br />
epi<strong>the</strong>lia, localise at <strong>the</strong> adherens junctions (AJs). Analysis of<br />
Drosophila E-Cadherin mutant embryos suggests that DE-Cadherin<br />
regulation during Dorsal Closure (DC) relies mainly on posttranscriptional<br />
regulation. In this study, we <strong>de</strong>veloped an assay to<br />
assess <strong>the</strong> dynamics of DE-Cadherin. This assay revealed that native<br />
DE-Cadherin has different antibody binding properties <strong>de</strong>pending on<br />
its location and <strong>the</strong> antibody used, which has never been observed in<br />
fixed DE-Cadherin in Drosophila embryos. A monoclonal antibody<br />
against <strong>the</strong> extracellular domain of DE-Cadherin labels amnioserosa<br />
(AS) and dorsal-most epi<strong>de</strong>rmal (DME) cells, but not <strong>the</strong> lateral<br />
epi<strong>de</strong>rmal cells, which contrasts with a polyclonal antibody that labels<br />
all epi<strong>de</strong>rmal cells. These differences could result from different<br />
conformation/organization of <strong>the</strong> Cadherins that confer different<br />
adhesive strengths. Regional modulation of adhesion could represent<br />
a general mechanism in morphogenesis, ensuring <strong>the</strong> maintenance of<br />
adhesion in key regions of <strong>the</strong> tissue subjected to more tension.<br />
47
Control of tissue growth and homeostasis by <strong>the</strong> integrated activities<br />
of Hippo signaling and Drosophila Myc<br />
Neto-Silva RM (1) (2) (*) and Johnston LA (2)<br />
(1) <strong>Gulbenkian</strong> PhD Programme in Biomedicine, <strong>Instituto</strong> <strong>Gulbenkian</strong><br />
<strong>de</strong> Ciencia, Rua da Quinta Gran<strong>de</strong>, 6, P-2780-156 Oeiras, Portugal<br />
(2) Department of Genetics and Development, Columbia University<br />
Medical Center, 701 West 168th Street, New York, NY 10032, USA<br />
(*) Present address - Champalimaud Neuroscience Programme at<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> Ciencia, Rua da Quinta Gran<strong>de</strong>, 6, P-2780-<br />
156 Oeiras, Portugal<br />
An un<strong>de</strong>rstanding of how animal size is controlled requires knowledge<br />
of how positive and negative growth regulatory signals are balanced<br />
and integrated within cells. I will present data showing that <strong>the</strong><br />
activities of <strong>the</strong> conserved growth-promoting transcription factor Myc<br />
and <strong>the</strong> tumor-suppressing Hippo pathway are co<strong>de</strong>pen<strong>de</strong>nt during<br />
growth of Drosophila imaginal discs. We find that Yorkie (Yki), <strong>the</strong><br />
Drosophila homolog of <strong>the</strong> Hippo pathway transducer, Yap, regulates<br />
<strong>the</strong> transcription of Myc, and that Myc functions as a critical cellular<br />
growth effector of <strong>the</strong> pathway. We <strong>de</strong>monstrate that in turn, Myc<br />
regulates <strong>the</strong> expression of Yki as a function of its own cellular level,<br />
such that high levels of Myc repress Yki expression through both<br />
transcriptional and posttranscriptional mechanisms. We propose that<br />
<strong>the</strong> co<strong>de</strong>pen<strong>de</strong>nt regulatory relationship functionally coordinates <strong>the</strong><br />
cellular activities of Yki and Myc, and provi<strong>de</strong>s a mechanism of growth<br />
control that regulates organ size and has potential implications for<br />
cancer.<br />
48
Slitrk5 a new neuronal protein implicated in obsessive-compulsivelike<br />
behaviors in mice<br />
Proenca CC, Shmelkov SV, Ninan I, Rafii S and Lee FS<br />
Weill Cornell Medical College, New York<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> Ciencia, Oeiras<br />
New York University Langone Medical Center, New York,<br />
Obsessive-compulsive disor<strong>de</strong>r (OCD) is a common psychiatric<br />
disor<strong>de</strong>r <strong>de</strong>fined by <strong>the</strong> presence of obsessive thoughts and repetitive<br />
compulsive actions, and often encompasses anxiety and <strong>de</strong>pressive<br />
symptoms as well. Recently, <strong>the</strong> cortico-striatal circuitry has been<br />
implicated in <strong>the</strong> pathogenesis of OCD. However, <strong>the</strong> etiology and<br />
pathophysiology of OCD is still not un<strong>de</strong>rstood and <strong>the</strong> molecular<br />
basis is not known. Several studies indicate that pathogenesis of OCD<br />
has a genetic component. Here we <strong>de</strong>monstrate that loss of a<br />
neuron-specific transmembrane protein, Slitrk5, leads to OCD<br />
behaviors in mice, which manifests in excessive self-grooming and<br />
anxiety, and is alleviated by <strong>the</strong> selective serotonin reuptake<br />
inhibitor, fluoxetine. slitrk5-/- mice display selective abnormalities in<br />
striatal anatomy and cell morphology, as well as alteration in striatal<br />
glutamate receptor composition, which contribute to <strong>de</strong>ficient corticostriatal<br />
neurotransmission in adult mice. Thus, our studies i<strong>de</strong>ntify<br />
Slitrk5 as an essential molecule at <strong>the</strong> cortical-striatal synapses, and<br />
provi<strong>de</strong> a novel mo<strong>de</strong>l to screen for pharmacological agents for <strong>the</strong><br />
treatment of OCD.<br />
49
Forced NF-kappaB in T cells leads to Tumor Rejection<br />
Cesar Evaristo (1) Thomas Gajewski (2) and Maria-Luisa Alegre (1)<br />
(1) Department of Medicine<br />
(2) Department of Pathology, University of Chicago, Chicago, IL<br />
NF-kappaB activity has been reported to be reduced in T cells from<br />
tumor-bearing hosts. Our previous results indicate that reduced NFkappaB<br />
activation results in impaired survival of T cells, <strong>de</strong>creased<br />
Th1 and Th17 differentiation and increased iTreg differentiation. Mice<br />
with reduced T cell-NF-kappaB activity fail to reject cardiac and<br />
pancreatic islet allografts in <strong>the</strong> absence of any pharmacological<br />
treatment. We hypo<strong>the</strong>size that forced activation of NF-kappaB in T<br />
cells should have <strong>the</strong> opposite effect and promote T cell survival,<br />
facilitate Th1/Th17 differentiation and prevent iTreg differentiation,<br />
which would be beneficial to reject tumors. We generated mice with<br />
constitutively active IKKbeta in T cells (henceforth CA-IKKbeta mice).<br />
Ectopic expression of CA-IKKbeta resulted in phosphorylation of NFkappaB.<br />
Transgene expression was limited to CD4+, CD8+ and NKT<br />
cells and T cells showed increased NF-kappaB activation and nuclear<br />
translocation. T cell numbers were comparable to littermate controls,<br />
but CA-IKKbeta mice had fewer Tregs and increased frequency of<br />
activated T cells that produced IFNgamma upon re-stimulation. When<br />
B16-SIY melanoma cells were injected subcutaneously, tumors grew<br />
progressively in control littermates, whereas <strong>the</strong>y were rejected by<br />
mice expressing CA-IKKbeta in T cells. Fur<strong>the</strong>rmore, IKKbeta-CA<br />
expressing CD4+ and CD8+ T cells were necessary and sufficient for<br />
tumor control. Our results <strong>de</strong>monstrate NF-kappaB to be at <strong>the</strong> crossroads<br />
of major T cell fate <strong>de</strong>cisions that should uniquely synergize for<br />
control of tumor growth.<br />
50
Proteomics of Isolated Chromatin Segments<br />
José Antão (1) James M. Mason(2) Jérôme Ájardin (3) and Robert<br />
E. Kingston (1)<br />
(1) Department of Molecular Biology, Massachusetts General Hospital,<br />
Boston, USA<br />
(2)NIEHS, Research Triangle Park, NC, USA<br />
(3)Genetique Humaine, CNRS, Montpellier, France<br />
The regulation of any genomic locus is done, in large measure, by <strong>the</strong><br />
complement of proteins that bind to it in a given cellular context.<br />
Even though <strong>the</strong>re are some powerful tools for looking at protein<br />
localization in <strong>the</strong> genome through a candidate-based approach, an<br />
unbiased method for i<strong>de</strong>ntifying all proteins bound to a specific DNA<br />
element at a given time has been lacking. We have <strong>de</strong>veloped a<br />
method that uses a DNA/LNA-based oligonucleoti<strong>de</strong> probe to target<br />
and specifically purify genomic segments in <strong>the</strong>ir chromatin<br />
environment, and <strong>de</strong>termine <strong>the</strong>ir protein composition. Using this<br />
method, we have i<strong>de</strong>ntified proteins that bind to <strong>the</strong> Drosophila<br />
Telomeric-Associated Sequence (TAS) repeats and, through a genetic<br />
screen, we have confirmed <strong>the</strong> involvement of one of <strong>the</strong>se proteins<br />
in <strong>the</strong> control of Telomeric Position Effect (TPE), a gene silencing<br />
mechanism mediated by <strong>the</strong> TAS repeats.<br />
51
A genome-wi<strong>de</strong> RNAi screen for Neuroblast cell cycle exit in<br />
Drosophila<br />
Catarina C. Homem and Juergen A. Knoblich<br />
Institute of Molecular Biotechnology of <strong>the</strong> Austrian Aca<strong>de</strong>my of<br />
Sciences (IMBA)<br />
During <strong>de</strong>velopment, Drosophila neural stem cells, <strong>the</strong> Neuroblasts<br />
(Nbs), divi<strong>de</strong> asymmetrically to self-renew and to generate a<br />
differentiated Ganglion Mo<strong>the</strong>r Cell (GMC). The GMC divi<strong>de</strong>s once<br />
more to generate two post-mitotic neurons or glia. Drosophila Nbs<br />
un<strong>de</strong>rgo multiple rounds of divisions generating hundreds of neurons,<br />
which make up <strong>the</strong> nervous system of <strong>the</strong> fly. Drosophila Nbs divi<strong>de</strong><br />
throughout <strong>de</strong>velopment, but stop dividing and disappear just before<br />
entering adult stages. To maintain <strong>the</strong> correct number and type of<br />
neurons, it is essential to precisely regulate <strong>the</strong> time at which<br />
neurogenesis ceases. Although several factors influencing neural<br />
proliferation have been i<strong>de</strong>ntified, <strong>the</strong> un<strong>de</strong>rlying molecular<br />
mechanism scheduling <strong>the</strong> end of progenitor divisions remains<br />
enigmatic. Tight control of <strong>the</strong> number of self-renewing and<br />
differentiating daughter cells is also crucial to prevent uncontrolled<br />
proliferation and tumor formation.<br />
To i<strong>de</strong>ntify novel genes regulating stem cell proliferation and division<br />
termination we are carrying out a genome wi<strong>de</strong> in vivo RNAi screen<br />
using Nbs as a mo<strong>de</strong>l. In our assay we co-express Luciferase and<br />
RNA hairpins specifically in a subset of Nbs and <strong>the</strong>ir respective<br />
progeny. We <strong>the</strong>n measure luminescence amounts in <strong>the</strong> adult head<br />
to assess Nb number and lineage sizes.<br />
Up to now we have screened a total of 7500 RNAi lines targeting<br />
53.6% of <strong>the</strong> protein coding genes in <strong>the</strong> Drosophila genome. We<br />
have i<strong>de</strong>ntified significant increases in luminescence in 6.8% of <strong>the</strong><br />
RNAi lines screened, corresponding to 402 genes. In this group, we<br />
expect to find several classes of genes involved in <strong>the</strong> regulation of<br />
Nb size, life-span and proliferation.<br />
Consistent with our hypo<strong>the</strong>sis, among <strong>the</strong>se we find Brat, Numb and<br />
Miranda, known to cause Nb number increase and tumor formation.<br />
In a secondary analysis by immunofluorescence we have, so far,<br />
i<strong>de</strong>ntified three previously uncharacterized potential tumor<br />
suppressors and two new genes potentially involved in Nb life-span<br />
regulation.<br />
52
A bit of T cell immunology, or playing a different type of CD<br />
Bruno Silva-Santos<br />
Insituto <strong>de</strong> Medicina Molecular, Lisboa<br />
For an immunologist, fellow non-immunologist scientists must be<br />
often treated as “lay audience” due to heavy jargon that inclu<strong>de</strong>s<br />
many CD numbers (CD3, CD127…) and an increasing amount of Th<br />
subsets (from Th1 to Th22 or more…). While keeping that in mind, I<br />
will try to summarize <strong>the</strong> research <strong>de</strong>veloped in my lab over <strong>the</strong> past<br />
4 years. It will be a rapid journey on T cell differentiation and T cell<br />
responses to infectious microrganisms and tumours. Instead of <strong>the</strong><br />
most common CD4+ or CD8+ lymphocytes, we will mostly discuss<br />
<strong>the</strong> unconventional gamma-<strong>de</strong>lta T cell subset. I leave you <strong>the</strong> three<br />
take home messages: my favourite CD number is 27 because CD27<br />
plays key roles in thymic <strong>de</strong>velopment and peripheral expansion of<br />
gamma-<strong>de</strong>lta T cells; ULBP1 is <strong>the</strong> critical tumour antigen for gamma<strong>de</strong>lta<br />
T cell recognition of haematological tumours; and we are now<br />
studying <strong>the</strong> molecular (epigenetic-to-transcriptional-to-posttranscriptional)<br />
mechanisms of Th1 and Th17 differentiation in vivo…<br />
Well, I will try to be clearer during <strong>the</strong> talk…<br />
53
Quiescent neuroblasts are reactivated via TOR and paracrine Insulin<br />
relays in Drosophila<br />
Rita Sousa-Nunes, Lih Ling Yee and Alex P. Gould<br />
Division of Developmental Neurobiology, Medical Research Council<br />
National Institute for Medical Research, The Ridgeway, Mill Hill,<br />
London NW7 1AA, UK<br />
Many stem, progenitor and cancer cells un<strong>de</strong>rgo periods of mitotic<br />
quiescence from which <strong>the</strong>y can be reactivated. The signals triggering<br />
entry into and exit from this reversible dormant state are not well<br />
un<strong>de</strong>rstood. Multipotent self-renewing progenitors in <strong>the</strong> <strong>de</strong>veloping<br />
Drosophila central nervous system (CNS), termed neuroblasts,<br />
un<strong>de</strong>rgo quiescence in a stereotypical spatiotemporal pattern. Entry<br />
into quiescence is regulated by Hox proteins and an internal<br />
neuroblast timer. Exit from quiescence (reactivation) is subject to a<br />
nutritional checkpoint requiring dietary amino acids. Organ co-culture<br />
experiments also implicate an uni<strong>de</strong>ntified signal from an<br />
adipose/hepatic-like tissue called fat body. However, it has been<br />
unclear how <strong>the</strong>se CNS-extrinsic nutritional cues are transmitted to<br />
quiescent neuroblasts. Here, we provi<strong>de</strong> in vivo evi<strong>de</strong>nce that<br />
neuroblasts are able to sense amino acids indirectly, via a tissue-totissue<br />
relay: fat body and CNS glia, neurons and neuroblasts. We find<br />
that a signal secreted by <strong>the</strong> fat body, <strong>de</strong>pen<strong>de</strong>nt upon amino-acid<br />
and Target-of-Rapamycin (TOR) signalling, is required for neuroblasts<br />
to exit quiescence. We also <strong>de</strong>monstrate that Insulin-like Pepti<strong>de</strong>s<br />
(Ilps), produced by CNS glia/neurons in a nutrient-<strong>de</strong>pen<strong>de</strong>nt<br />
manner, are necessary and sufficient for timely neuroblast<br />
reactivation but do not regulate overall larval size. Conversely,<br />
systemic Ilps secreted into <strong>the</strong> hemolymph by median neurosecretory<br />
cells (mNSCs) regulate organismal size but do not reactivate<br />
neuroblasts. Drosophila thus contains two segregated Ilp pools, one<br />
regulates neuroblast proliferation within <strong>the</strong> CNS and <strong>the</strong> o<strong>the</strong>r<br />
controls tissue growth systemically. Toge<strong>the</strong>r, our findings support a<br />
tissue relay mo<strong>de</strong>l in which amino-acid sensing by <strong>the</strong> fat body<br />
stimulates Insulin signalling from glia/neurons, triggering<br />
Phosphatidylinositol 3-Kinase (PI3K)/TOR activation in neuroblasts, in<br />
turn leading to cell cycle re-entry. This mechanism links syst<br />
emic and tissue-restricted signals to neural proliferation and, more<br />
generally, highlights that dietary nutrients and remote organs are key<br />
regulators of transitions in stem-cell behaviour.<br />
54
CISA Project – Developing a Health Research Center in Angola<br />
Susana Vaz Nery<br />
CISA Project<br />
The “CISA Project”, a partnership between <strong>the</strong> Angolan Ministry of<br />
Health, <strong>the</strong> Bengo Provincial Government, <strong>the</strong> Portuguese<br />
Development Aid Institute and <strong>the</strong> <strong>Calouste</strong> <strong>Gulbenkian</strong> Foundation,<br />
aims to <strong>de</strong>velop a Health Research Centre in Angola (CISA), located<br />
in <strong>the</strong> city of Caxito, Dan<strong>de</strong>´s municipality, Bengo´s Province.<br />
The “CISA Project” promotes epi<strong>de</strong>miological and clinical research on<br />
<strong>the</strong> most prevalent or relevant diseases in Angola, such as malaria,<br />
tuberculosis and neglected tropical diseases (including<br />
schistosomiasis and intestinal parasitoses).<br />
The <strong>Calouste</strong> <strong>Gulbenkian</strong> Foundation leads <strong>the</strong> CISA Project<br />
management, whereas in Caxito research activity is implemented by<br />
a team of more than 60 people.<br />
In 2009 a Demographic Surveillance System (DSS) has been<br />
established, with <strong>the</strong> aim of characterizing <strong>the</strong> size and dynamics of<br />
Dan<strong>de</strong>´s population and its geographical distribution, thus providing<br />
background information for epi<strong>de</strong>miological studies. The initial census<br />
of <strong>the</strong> DSS-Dan<strong>de</strong> was completed in April 2010, covering a population<br />
of more than 60,000 resi<strong>de</strong>nts.<br />
A baseline prevalence survey on malaria, schistosomiasis, intestinal<br />
parasitoses, anaemia and malnutrition in <strong>the</strong> DSS study area is being<br />
completed, and it will sample approximately 3000 people. In parallel<br />
to this study an ethnobotanic baseline survey was also implemented.<br />
O<strong>the</strong>r scientific activities initiated in 2010 inclu<strong>de</strong>: 1) a pilot to<br />
establish a verbal autopsy system in or<strong>de</strong>r to <strong>de</strong>termine <strong>the</strong> main<br />
causes of <strong>de</strong>aths that happen in <strong>the</strong> community; and 2) a pediatrics<br />
clinical surveillance system that will provi<strong>de</strong> a platform for clinical<br />
research studies besi<strong>de</strong>s improving <strong>the</strong> quality of documentation and<br />
care at <strong>the</strong> hospital.<br />
55
Adaptation in Escherichia coli<br />
Isabel Gordo<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> Ciencia<br />
Adaptation involves changes in <strong>the</strong> genotype, which will <strong>the</strong>n have<br />
phenotypic consequences that increase <strong>the</strong> ability of survival and<br />
reproduction of organisms in a given environment. The problem is<br />
that organisms adapt through mutations that are random with<br />
respect to <strong>the</strong>ir needs. In or<strong>de</strong>r to un<strong>de</strong>rstand <strong>the</strong> process of<br />
adaptation we are performing experimental evolution. We are<br />
studying <strong>the</strong> rate and effects of adaptive mutations in populations of<br />
Escherichia coli, adapting to different environments. We interpret our<br />
results on <strong>the</strong> fitness effects of new adaptive mutations in <strong>the</strong> light of<br />
Fisher's geometrical mo<strong>de</strong>l and are <strong>de</strong>veloping <strong>the</strong>oretical extensions<br />
of this mo<strong>de</strong>l.<br />
56
Membrane trafficking in synaptic <strong>de</strong>velopment<br />
Rita O. Teodoro and Thomas L. Schwarz<br />
F.M. Kirby Neurobiology Center, Children’s Hospital Boston and<br />
Department of Neurobiology, Harvard Medical School<br />
Neurons are specialized cells that can extend over great distances,<br />
enabling <strong>the</strong> complex networking of <strong>the</strong> nervous system. Like all<br />
o<strong>the</strong>r eukaryotic cells, it is essential for neurons to have tight spatial<br />
control of exocytosis in or<strong>de</strong>r to form and maintain specialized<br />
domains within <strong>the</strong> cell. Membrane trafficking is emerging as a key<br />
aspect of neuronal <strong>de</strong>velopment and function. The exocyst is a<br />
protein complex linked to membrane traffic and one way it is<br />
regulated is by its interaction with several small GTPases, including<br />
RalA. Although not required for <strong>the</strong> exocytosis of synaptic vesicles,<br />
<strong>the</strong> exocyst may be important in o<strong>the</strong>r aspects of synapse growth and<br />
plasticity through its involvement in and regulation of <strong>the</strong> te<strong>the</strong>ring,<br />
docking and fusion of post-Golgi vesicles with <strong>the</strong> plasma membrane.<br />
I will present evi<strong>de</strong>nce of a signaling pathway by which synaptic<br />
activation can recruit <strong>the</strong> exocyst complex to postsynaptic zones and<br />
promote growth of postsynaptic membranes. For a more complete<br />
un<strong>de</strong>rstanding of <strong>the</strong> molecular pathways by which <strong>the</strong> exocyst<br />
contributes to synaptic <strong>de</strong>velopment, we did a forward genetic screen<br />
to i<strong>de</strong>ntify genes that interact with <strong>the</strong> exocyst member Sec5.<br />
Altoge<strong>the</strong>r, our studies i<strong>de</strong>ntified a novel pathway by which synaptic<br />
activity, with its concomitant influx of Ca2+, can contribute to <strong>the</strong><br />
<strong>de</strong>velopment of <strong>the</strong> post-synapse and, potentially, to a form of<br />
activity-<strong>de</strong>pen<strong>de</strong>nt plasticity involving membrane growth. Finally, we<br />
hope to fur<strong>the</strong>r un<strong>de</strong>rstand and dissect new pathways that contribute<br />
to synaptic <strong>de</strong>velopment and plasticity by uncovering new genes that<br />
genetically interact with exocyst.<br />
57
Host-Microorganism Interactions<br />
Luis Teixeira<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />
Multicellular organisms and microorganisms are continuously<br />
interacting. Many of <strong>the</strong>se interactions are mutually beneficial.<br />
However, multicellular organisms have to actively thwart invasion by<br />
opportunistic or overtly pathogenic microbes. We are studying <strong>the</strong><br />
interaction of <strong>the</strong> mo<strong>de</strong>l organism Drosophila melanogaster with<br />
different microorganisms, in particular intracellular ones.<br />
D. melanogaster has been successfully used as a mo<strong>de</strong>l system to<br />
study innate immunity against many pathogens. Recently it has been<br />
shown that <strong>the</strong>re are innate immunity pathways against viruses<br />
conserved between insects and mammals. We are investigating<br />
mechanisms of resistance to viruses in <strong>the</strong> fruit fly.<br />
Interestingly, we have found that <strong>the</strong> intracellular bacteria Wolbachia<br />
confer resistance to RNA viruses in D. melanogaster. We want to<br />
un<strong>de</strong>rstand <strong>the</strong> molecular basis of this induced resistance.<br />
Finally, we are interested in <strong>the</strong> interplay between Drosophila and<br />
Wolbachia itself. These endosymbionts are one of <strong>the</strong> most<br />
wi<strong>de</strong>spread intracellular bacteria in <strong>the</strong> world but little is known, at<br />
<strong>the</strong> molecular level, on how <strong>the</strong> hosts control Wolbachia or Wolbachia<br />
manipulate <strong>the</strong> hosts.<br />
58
Into <strong>the</strong> molecular nature of <strong>the</strong> telomeric checkpoint Inhibition<br />
Tiago Carneiro and Miguel Godinho Ferreira<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, Oeiras, Portugal<br />
Telomeres, <strong>the</strong> natural chromosome ends of eukaryotes, have unique<br />
properties that distinguish <strong>the</strong>m from damage-induced DNA double<br />
strand breaks (DSB). Whereas a single DSB can halt cell cycle<br />
progression and activate repair processes, telomeres prohibit<br />
checkpoint activation and DNA repair. Never<strong>the</strong>less, several<br />
components involved in DNA damage response (DDR) are critical for<br />
end protection and must be controlled at telomeres to prevent<br />
checkpoints.<br />
We recently showed that telomeres constitute a chromatin-privileged<br />
region capable of stably mounting DDRs without blocking <strong>the</strong> cell<br />
cycle.<br />
Ra<strong>the</strong>r than preventing recruitment and activation of Rad3ATR<br />
kinase, telomeres exclu<strong>de</strong> <strong>the</strong> mediator Crb253BP1 protein thus<br />
preventing DDR amplification and full checkpoint response. In<br />
contrast to <strong>the</strong> rest of <strong>the</strong> genome, H4K20me2 (but not γH2A) is<br />
absent from telomeres. Lack of H4K20me2 from chromosome-ends<br />
cannot be explained by absence of Set9 methyltransferase. Not only<br />
telomeres exhibit Set9-<strong>de</strong>pen<strong>de</strong>nt mono and trimethylated forms of<br />
H4K20 but also artificial recruitment of Set9 to chromosome-ends<br />
does not restore a full checkpoint response.<br />
We are currently investigating how telomere heterochromatin<br />
exclu<strong>de</strong>s H4K20me2. We are <strong>de</strong>vising two complementary assays: 1-<br />
we hope to <strong>de</strong>termine sufficiency of telomere proteins to prevent<br />
checkpoints by te<strong>the</strong>ring <strong>the</strong>m adjacent to a HO-induced double<br />
strand break; 2- conversely, we are analysing internal telomere<br />
sequences to study whe<strong>the</strong>r <strong>the</strong>se are sufficient to modify <strong>the</strong><br />
surrounding chromatin and exclu<strong>de</strong> epigenetic markers required for<br />
checkpoint response.<br />
59
Fundraising for science-New approaches for research funding in<br />
Portugal<br />
Maria João Leão<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> Ciencia, Lisboa, Portugal<br />
IGC has recently begun to <strong>de</strong>velop fundraising initiatives that involve<br />
<strong>the</strong> scientific community, <strong>the</strong> private sector and <strong>the</strong> general public.<br />
This project aims to establish alternative means of financial resources<br />
for research in Portugal and to contribute to a closer interaction<br />
between Research Institutions and <strong>the</strong> Portuguese society.<br />
60
Plenary Session<br />
Jonathan Howard<br />
Univeristy of Colgne, Germany<br />
“How to build a perfect institute”<br />
62
ABSTRACTS FOR ORAL PRESENTATIONS<br />
Tuesday 28 December<br />
SESSION FOUR<br />
64
The force of <strong>the</strong> pulsating collective<br />
Antonio Jacinto<br />
Insituto <strong>de</strong> Medicina Molecular, Lisboa<br />
We still do not know very much about coordination of forces<br />
generated by cells during morphogenesis. It amazes me how an<br />
entity with <strong>the</strong> complexity, fluidity, and softness of a cell can work<br />
with its neighbours to drive dynamic but extremely robust tissue<br />
shape changes that occur during embryogenesis or regeneration. I<br />
will tour recent results from our group that highlight <strong>the</strong> importance<br />
of non-monotonic cell behaviours; pulses of forces generated by <strong>the</strong><br />
actomyosin network seem to be one of <strong>the</strong> crucial strategies that cells<br />
use to work toge<strong>the</strong>r to produce from.<br />
66
Overview of <strong>the</strong> Cell Death Regulaion Laboratory<br />
Luis Miguel Martins<br />
Medical Research Council Toxicology, Leicester University, UK<br />
Tissue homeostasis relies on <strong>the</strong> tightly controlled removal of<br />
superfluous, damaged and ectopic cells, normally through apoptosis.<br />
Whereas an aberrant resistance to apoptosis participates in <strong>the</strong><br />
<strong>de</strong>velopment of neoplasias, excessive cell <strong>de</strong>ath, through apoptosis or<br />
necrosis, contributes to acute organ failure as well as to chronic<br />
diseases involving <strong>the</strong> loss of post-mitotic cells.<br />
The focus of our research is to better un<strong>de</strong>rstand <strong>the</strong> control of<br />
cellular <strong>de</strong>ath processes in normal cells as well as in pathological<br />
states where alterations of <strong>the</strong>se processes have occurred.<br />
Our aim is to achieve a better un<strong>de</strong>rstanding of <strong>the</strong> regulatory<br />
mechanisms controlling cell <strong>de</strong>ath. Un<strong>de</strong>rstanding <strong>the</strong> basic biology of<br />
<strong>the</strong>se processes can provi<strong>de</strong> insights that might lead to targeted<br />
treatment solutions that will act on pathways and alter disease at its<br />
cause resulting in a better type of medicine.<br />
67
Establishment of asymmetries in <strong>the</strong> early vertebrate embryo<br />
José António Belo<br />
(1) Regenerative Medicine Program, Departamento <strong>de</strong> <strong>Ciência</strong>s<br />
Biomédicas e Medicina, Universida<strong>de</strong> do Algarve, Portugal<br />
(2) IBB-Institute for Biotechnology and Bioengineering, Centro <strong>de</strong><br />
Biomedicina Molecular e Estrutural, Universida<strong>de</strong> do Algarve, Portugal<br />
(3) <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, Oeiras, Portugal<br />
One fundamental aspect of vertebrate embryonic <strong>de</strong>velopment is <strong>the</strong><br />
formation of <strong>the</strong> body plan. For this process, asymmetries have to be<br />
generated during early stages of <strong>de</strong>velopment along <strong>the</strong> three main<br />
body axes: Anterior-Posterior, Dorso-Ventral and Left-Right. We have<br />
been studying <strong>the</strong> role of a novel class of molecules, <strong>the</strong><br />
Cerberus/Dan gene family. These are <strong>de</strong>dicated secreted antagonists<br />
of three major signaling pathways: Nodal, BMP and Wnt. Our studies<br />
contribute to <strong>the</strong> current view that <strong>the</strong> fine tuning of signaling is<br />
controlled by a set of inhibitory molecules ra<strong>the</strong>r than by activators.<br />
In this context, <strong>the</strong> Cerberus-like molecules emerge as key players in<br />
<strong>the</strong> regulation and generation of asymmetries in <strong>the</strong> early vertebrate<br />
embryo. Recent studies conducted in our lab unraveled <strong>the</strong> role of<br />
<strong>the</strong>se molecules during organogenesis as well.<br />
68
Development on time: <strong>the</strong> embryonic molecular clock<br />
Isabel Palmeirim<br />
Medical and Biomedical Sciences Department, Bio-regenerative<br />
Medicine Program, IBB-Institute for Biotechnology and<br />
Bioengineering, Centre for Molecular and Structural Biomedicine,<br />
University of Algarve, Campus <strong>de</strong> Gambelas, 8005-139<br />
Alongsi<strong>de</strong> <strong>the</strong> three dimensions in which an embryo un<strong>de</strong>rgoes<br />
growth and differentiation, one can consi<strong>de</strong>r TIME as being a fourth<br />
dimension, which must experience equally tight regulatory<br />
mechanisms in or<strong>de</strong>r to assure that each tissue/structure/organ is<br />
formed in <strong>the</strong> right place, at <strong>the</strong> right time. Time control is<br />
particularly evi<strong>de</strong>nt during <strong>the</strong> process by which <strong>the</strong> vertebrate<br />
presomitic meso<strong>de</strong>rm is progressively segmented into repeated units,<br />
named somites. Somites arise in a highly coordinated way both in<br />
space and time and, later on, give rise to vertebrae, intervertebral<br />
discs, ribs and skeletal muscles. In 1997, <strong>the</strong> first molecular evi<strong>de</strong>nce<br />
for <strong>the</strong> existence of an intrinsic cellular molecular clock un<strong>de</strong>rlying <strong>the</strong><br />
rhythm of somitogenesis has been provi<strong>de</strong>d. We currently know that<br />
this clock operates in all vertebrate groups studied, in more than one<br />
embryonic tissue, with different time-periods and an increasing<br />
number of genes belonging to <strong>the</strong> Notch, FgF and Wnt<br />
signalling pathways are being implicated in this clocked mechanism.<br />
Recently, our work brings forth new results, evi<strong>de</strong>ncing <strong>the</strong> role of<br />
Shh signaling pathway in pacing molecular clock gene expression and<br />
timing morphological somite formation. We believe that a <strong>de</strong>eper<br />
un<strong>de</strong>rstanding of <strong>the</strong> role and regulation of this embryonic<br />
mechanism is of crucial importance, since temporal control of<br />
biological processes is a transversal issue in all life sciences research<br />
fields.<br />
69
NK cells in Preeclampsia<br />
Ana Sofia Cer<strong>de</strong>ira, Hernan D. Kopcow, Zaheed Husain, Agnes Lo,<br />
Caroline Royle, Ravi I. Thadhani, Isaac Stillman, Vikas P. Sukhatme<br />
and S. Ananth Karumanchi<br />
<strong>Gulbenkian</strong> Programme for Advanced Medical Education<br />
Beth Israel Deaconess Medical Center/Harvard Medical School<br />
Serviço <strong>de</strong> Ginecologia e Obstetricia Centro Hospitalar do Porto<br />
Preeclampsia is a pregnancy disease characterized by new onset<br />
hypertension and proteinuria. It is a leading cause of maternal and<br />
perinatal morbidity and mortality complicating 3-8% pregnancies.<br />
Recent evi<strong>de</strong>nce suggests that Natural Killer (NK) cell signaling at <strong>the</strong><br />
maternal-fetal interface is an important regulator of maternal spiral<br />
artery remo<strong>de</strong>ling. This process is impaired in preeclampsia and leads<br />
to increased expression of placental soluble factors such as sFlt1 that<br />
induce <strong>the</strong> systemic manifestations of <strong>the</strong> disease. NK cells are<br />
abundant at <strong>the</strong> maternal <strong>de</strong>cidua (dNK) during <strong>the</strong> first trimester of<br />
pregnancy, and show severely reduced cytotoxicity and secretion of<br />
proangiogenic factors like VEGF. In contrast, peripheral blood NK cells<br />
(pNK) are cytotoxic and non-angiogenic. We hypo<strong>the</strong>sized that a<br />
combination of hypoxia and immunosuppressive cytokines like TGF-<br />
β1, known to be present in <strong>the</strong> placenta, may turn pNKs into dNKlike<br />
proangiogenic cells with reduced cytotoxicity.<br />
Like dNKs, pNKs cultured un<strong>de</strong>r hypoxia secreted VEGF and induced<br />
tube formation by HUVECs. Un<strong>de</strong>r hypoxia in <strong>the</strong> presence of TGF-β1<br />
pNKs showed reduced cytotoxicity. Since placenta and tumor<br />
microenvironment share many features, we characterized tumor<br />
infiltrating NK cells (tiNK) to better un<strong>de</strong>rstand this phenomenon.<br />
tiNK cells isolated from kidney tumors, like dNKs, show reduced<br />
cytotoxicity and secrete VEGF. Moreover, pNK cells exposed to<br />
hypoxia and TGF-β1 support tumor growth in a mouse mo<strong>de</strong>l of<br />
cancer. The hypoxic and immunosuppressive microenvironment of<br />
both tumor and placenta may co-opt NK cells transforming <strong>the</strong>m into<br />
poorly cytotoxic cells that secrete VEGF. In vitro conversion of pNKs<br />
into angiogenic dNK-like cells may have potential applications in <strong>the</strong><br />
<strong>de</strong>velopment of novel <strong>the</strong>rapeutic approaches for preeclampsia.<br />
70
The heterogenous behavior of human breast cancer<br />
Sofia Braga (1,2,3) and José B. Pereira-Leal (1)<br />
(1) <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong> - Oeiras, Portugal<br />
(2) <strong>Instituto</strong> Português <strong>de</strong> Oncologia - Lisboa, Portugal<br />
(3) Programa <strong>Gulbenkian</strong> <strong>de</strong> Formação Médica Avançada<br />
BC is a heterogenous disease. There are three subtypes of BC,<br />
<strong>de</strong>fined by immunohistochemical <strong>de</strong>tection of specific proteins, with<br />
prognostic and <strong>the</strong>rapeutic implications: ER positive BC, half of which<br />
also express <strong>the</strong> PgR, Her2 positive BC, and Triple negative BC. ER+<br />
BC is generally consi<strong>de</strong>red easier to manage clinically because of <strong>the</strong><br />
sensitivity to anti-estrogenic <strong>the</strong>rapy, Her2+ is treated with anti-Her2<br />
<strong>the</strong>rapy but has worse prognosis and TNBC has no validated targeted<br />
<strong>the</strong>rapy having <strong>the</strong> worse prognosis. Clinicians observe heterogeneity<br />
in <strong>the</strong> outcome of BC: not all ER+ BC are cured, some Her2+ BC<br />
relapse during <strong>the</strong>rapy and not all TNBC have a uniformly dismal<br />
prognosis. Our goal is to dissect <strong>the</strong> molecular basis of this<br />
heterogeneity. We already compiled and analyzed publicly available<br />
expression data (microarrays) from 3500 human tumors with<br />
outcome annotation. We performed subtype selection by standard<br />
immunohistochemical annotation and by using a computational<br />
algorithm. We used classical supervised methods for discovering<br />
genes and pathways that are differentially expressed in tumours with<br />
differing outcome. We have generated a set of potential prognostic<br />
markers for each subtype of BC that we are now fur<strong>the</strong>r<br />
investigating. The next step in this analysis is a prospective<br />
validation of <strong>the</strong> prognostic value of <strong>the</strong>se genes and pathways in<br />
collaboration with pathologists at public hospitals in Lisbon.<br />
71
Different tasks, different tra<strong>de</strong>offs: speed and accuracy in odor<br />
<strong>de</strong>tection vs. odor categorization<br />
Maria I. Vicente, André G. Mendonça, Zachary F. Mainen<br />
Systems Neuroscience Lab, Champalimaud Neuroscience Programme<br />
Speed-accuracy tra<strong>de</strong>offs (SATs) are well known in cognitive and<br />
perceptual <strong>de</strong>cision-making, and can involve large (>50%) changes<br />
in processing time. However, in some tasks, such as odor mixture<br />
categorization, much smaller SATs (or<strong>de</strong>r 10%) are observed. Why<br />
some tasks benefit more from temporal processing than o<strong>the</strong>rs is not<br />
well un<strong>de</strong>rstood.<br />
We hypo<strong>the</strong>size that <strong>the</strong> <strong>de</strong>gree of SAT <strong>de</strong>pends on <strong>the</strong> relative<br />
contribution of sensory and non-sensory noise. To test this i<strong>de</strong>a, we<br />
compared SAT in <strong>the</strong> odor mixture categorization task to that in a<br />
new two alternative choice odor <strong>de</strong>tection task, using <strong>the</strong> same odors<br />
diluted up to 1,000-fold. The same rats performed both tasks and all<br />
o<strong>the</strong>r task variables were held constant. We envisaged that stimulus<br />
noise would dominate <strong>the</strong> <strong>de</strong>tection but not <strong>the</strong> categorization task.<br />
As predicted, we found that SAT (difference in reaction time, RT, from<br />
<strong>the</strong> easiest to <strong>the</strong> har<strong>de</strong>st problem) was much larger in <strong>the</strong> odor<br />
<strong>de</strong>tection task (53% increase in RT as accuracy <strong>de</strong>creased from 97%<br />
to 62%) than in <strong>the</strong> mixture categorization task (14% increase for a<br />
similar change in accuracy). These data <strong>de</strong>monstrate that sensory<br />
integration and <strong>the</strong> amount of SAT are problem-specific and suggest<br />
that <strong>the</strong> locus of performance-limiting noise is a critical variable.<br />
72
Chromatin dynamics in motor skill learning<br />
Galvão-Ferreira P. and Costa R. M.<br />
Champalimaud Neuroscience Program at <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong><br />
Ciencia, Rua da Quinta Gran<strong>de</strong> 6, 2781-901 Oeiras, Portugal<br />
Motor skills can last a lifetime. In previous work, we have shown that<br />
motor skill learning involves changes in synaptic plasticity in <strong>the</strong><br />
striatum which evolve with training. In addition, we observed<br />
differential involvement of striatal output circuits (namely,<br />
striatonigral and striatopallidal circuits) in skill authomatization. In<br />
recent years, both DNA methylation and post-translational<br />
modifications of nuclear proteins have been implicated in<br />
physiologically normal mechanisms (such as synaptic plasticity and<br />
memory formation) as well as in neuropathological contexts. Yet, <strong>the</strong><br />
involvement of <strong>the</strong>se epigenetic mechanisms in motor skill learning<br />
has not been investigated.<br />
To test for <strong>the</strong> involvement of <strong>the</strong>se biochemical mechanisms in skill<br />
learning, we trained young and old mice (2 and 8 months old,<br />
respectively) in a lever-pressing task, in which subjects had to press<br />
<strong>the</strong> lever at up to 8Hz. Next, using DRD1-GFP and DRD2-GFP reporter<br />
mice to distinguish between D1-expressing and D2-expressing<br />
medium spiny (respectively, striatonigral and striatopallidal) neurons,<br />
we inquired whe<strong>the</strong>r epigenetic changes could be found in <strong>the</strong>se two<br />
circuits through immunohistochemistry and Western blotting.<br />
Currently, we are using those same transgenic mouse lines in an<br />
effort to extract and purify striatonigral and striatopallidal neurons<br />
through fluorescent activated cell sorting (FACS). Using <strong>the</strong>se varied<br />
approaches, we intend to investigate if <strong>the</strong> long-lasting plasticity<br />
observed throughout skill learning involves <strong>de</strong>fined epigenetic<br />
mechanisms in <strong>the</strong> striatonigral and striatopallidal output circuits.<br />
73
Plenary Session<br />
Maria Leptin, EMBO, Germany<br />
“My Life in Science”<br />
74
Alexandra Borges<br />
Participants List<br />
<strong>Instituto</strong> <strong>de</strong> Investigaciones Biomédicas Alberto Sols, Spain<br />
borgalexandra@gmail.com<br />
Alexandra Capela<br />
StemCells Inc, USA<br />
alexandra.capela@stemcellsinc.com<br />
Alexandra Santos<br />
King's College London, Hospitais da Universida<strong>de</strong> <strong>de</strong> Coimbra, UK<br />
alexandrafigueirasantos@gmail.com<br />
Alexandre Raposo<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />
araposo@igc.gulbenkian.pt<br />
Ana Borges<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
aborges@igc.gulbenkian.pt<br />
Ana Campilho<br />
IBMC, PT<br />
anacampilho@ibmc.up.pt<br />
76
Ana Mateus<br />
Cambridge University, UK<br />
amam3@cam.ac.uk<br />
Ana Matos<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />
anamatos.ct.surgery@gmail.com<br />
Ana Sousa<br />
Hospital <strong>de</strong> Santa Maria, PT<br />
anabertasousa@gmail.com<br />
Ana Sofia Cer<strong>de</strong>ira<br />
Beth Israel Deconess Medical Center, USA<br />
ana.cer<strong>de</strong>ira@gmail.com<br />
Ana Teresa Tavares<br />
CIISA-FMV, PT<br />
atavares@igc.gulbenkian.pt<br />
Ana Sanchez<br />
ITQB, PT<br />
asanchez@itqb.unl.pt<br />
77
António Coutinho<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />
coutinho@igc.gulbenkian.pt<br />
António Jacinto<br />
Inst. <strong>de</strong> Medicina Molecular, Fac. <strong>de</strong> Medicina da Univ. <strong>de</strong> Lisboa, PT<br />
ajacinto@fm.ul.pt<br />
Carla Martins<br />
Cancer Research, UK<br />
Carla.Martins@cancer.org.uk<br />
Catarina Homem<br />
Inst. of Molecular Biotech. of <strong>the</strong> Austrian Ac. of Sciences (IMBA), AUSTRIA<br />
catarina.homem@imba.oeaw.ac.at<br />
Cátia Proença<br />
<strong>Gulbenkian</strong>/Weill Cornell, USA<br />
cproenca@igc.gulbenkian.pt<br />
César Evaristo<br />
University of Chicago, USA<br />
cesar.evaristo@gmail.com<br />
78
Cláudio Gomes<br />
ITQB<br />
gomes@itqb.unl.pt<br />
David Cristina<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> da <strong>Ciência</strong>, PT<br />
davidc@igc.gulbenkian.pt<br />
Dinis Calado<br />
Harvard Medical School, USA<br />
calado@idi.harvard.edu<br />
Diogo Castro<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
dscastro@igc.gulbenkian.pt<br />
Diogo Lucena<br />
<strong>Fundação</strong> <strong>Calouste</strong> <strong>Gulbenkian</strong><br />
dlucena@gulbenkian.pt<br />
79
Diogo Pimentel<br />
DPAG- Oxford University, UK<br />
d.o.pimentel@gmail.com<br />
Eduardo Silva<br />
Wyss Institute/ Harvard University, USA<br />
easilva@wyss.harvard.edu<br />
Filipa Barbosa<br />
Insituto <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />
fbarbosa@igc.gulbenkian.pt<br />
Filipe Martins<br />
Dana-Farber Cancer Institute, UK<br />
filipecorreiamartins@gmail.com<br />
Francisco Dionísio<br />
Centro <strong>de</strong> Biologia Ambiental, Fac. <strong>de</strong> <strong>Ciência</strong>s Univ. <strong>de</strong> Lisboa, PT<br />
francisco.dionisio@gmail.com<br />
Fre<strong>de</strong>rico Regateiro<br />
University of Oxford, UK<br />
regateiro@gmail.com<br />
80
Guilherme Neves<br />
Molecular Neurobiology Div., MRC- Nat. Inst. for Medical Research, UK<br />
gneves@nimr.mrc.ac.uk<br />
Greta Martins<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />
gmartins@igc.gulbenkian.pt<br />
Helena Soares<br />
Pasteur Institute, FR<br />
helena.soares@pasteur.fr<br />
Inês Pires da Silva<br />
New York University, USA<br />
inespiresilva@gmail.com<br />
Isabel Campos<br />
IMM, PT<br />
icampos@fm.ul.pt<br />
Isabel Duarte<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
iduarte@igc.gulbenkian.pt<br />
81
Isabel Gordo<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
igordo@igc.gulbenkian.pt<br />
Isabel Palmeirim<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
palmeiri@igc.gulbenkian.pt<br />
Joana Barros<br />
Associação viver a ciência, PT<br />
jbarros@viveraciencia.org<br />
Joana Sá<br />
Harvard University, USA<br />
mjsa@fas.harvard.edu<br />
Joana Santos<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
joanars@igc.gulbenkian.pt<br />
Jonathan Howard<br />
Institute for Genetics<br />
82
José A. Belo<br />
Dep. <strong>de</strong> <strong>Ciência</strong>s Biomédicas e Medicina, Univ. Do Algarve, PT<br />
jbelo@ualg.pt<br />
José Antão<br />
Massachusetts General Hospital, USA<br />
antao@molbio.mgh.harvard.edu<br />
José Leal<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
jleal@igc.gulbenkian.pt<br />
Leonor Parreira<br />
Universida<strong>de</strong> <strong>de</strong> Lisboa, Faculda<strong>de</strong> <strong>de</strong> Medicina/ IGC<br />
lparreir@igc.gulbenkian.pt<br />
Lília Perfeito<br />
University of Cologne, GER<br />
lilia.perfeito@gmail.com<br />
L. Miguel Martins<br />
MRC Toxicology Unit, UK<br />
martins.lmiguel@gmail.com<br />
83
Luís Graça<br />
<strong>Instituto</strong> <strong>de</strong> Medicina Molecular, PT<br />
lgraca@fm.ul.pt<br />
Luis Soares<br />
Harvard Medical School, UK<br />
luis_soares@hms.harvard.edu<br />
Luis Teixeira<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
lteixeira@igc.gulbenkian.pt<br />
Manuel Batista<br />
Skirball Institute NYU, USA<br />
mfscb2@googlemail.com<br />
Manuel Rebelo<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
mrebelo@igc.gulbenkian.pt<br />
Margarida Trinda<strong>de</strong><br />
IMM, PT<br />
mtrinda<strong>de</strong>@fm.ul.pt<br />
84
Maria Inês Vicente<br />
Champalimaud Neuroscience Program at IGC, PT<br />
mivicente@igc.gulbenkian.pt<br />
Maria Leptin<br />
EMBO, Germany<br />
Maria Luisa Vasconcelos<br />
CNP at <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
vasconcelos@igc.gulbenkian.pt<br />
Maria João Leão<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
mjleao@igc.gulbenkian.pt<br />
Marta Nunes<br />
University of <strong>the</strong> Witwatersrand, SOUTH AFRICA<br />
mnunes00@yahoo.com<br />
Miguel Gaspar<br />
mangerico@gmail.com<br />
85
Miguel God. Ferreira<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
mgferreira@igc.gulbenkian.pt<br />
Miguel Remon<strong>de</strong>s<br />
MIT, USA<br />
remon<strong>de</strong>s@mit.edu<br />
Mónica Dias<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> da <strong>Ciência</strong>, PT<br />
mdias@igc.gulbenkian.pt<br />
Mónica Sousa<br />
IBMC, PT<br />
msousa@ibmc.up.pt<br />
Nuno Costa<br />
Institute of Neuroinformatics, Switzerland<br />
ndacosta@ini.phys.ethz.ch<br />
Ofélia P. De Carvalho<br />
University of Cambridge, UK<br />
omc20@cam.ac.uk<br />
86
Paula Duque<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
duquep@igc.gulbenkian.pt<br />
Paulo Ribeiro<br />
London Research Institute, Cancer Research, UK<br />
paulo.ribeiro@cancer.org.uk<br />
Pedro Batista<br />
Wake Forest Institute for Regenerative Medicine, USA<br />
pbaptist@wfubmc.edu<br />
Pedro Brites<br />
IBMC, PT<br />
pedro.brites@ibmc.up.pt<br />
Pedro Domingos<br />
ITQB, PT<br />
domingp@itqb.unl.pt<br />
Pedro Ferreira<br />
Champalimaud Neuroscience Program at IGC, PT<br />
pferreira@igc.gulbenkian.pt<br />
87
Perpétua Pinto-do-Ó<br />
INEB-<strong>Instituto</strong> Nacional <strong>de</strong> Engenharia Biomédica, PT<br />
perpetua@ineb.up.pt<br />
Ricardo Almeida<br />
University of Edinburgh, UK<br />
r.almeida@ed.ac.uk<br />
Ricardo Costa<br />
Centro Nacional <strong>de</strong> Investigaciones Cardiovasculares – CNIC, SP<br />
ricardo.costa@cnic.es<br />
Ricardo Neto Silva<br />
Champalimaud Neuroscience Programme at <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
ricmigneto@gmail.com<br />
Rita Sousa Nunes<br />
National Institute for Medical Research (NIMR), UK<br />
rsousa@nimr.mrc.ac.uk<br />
Rita Tavares<br />
University of California, San Francisco, USA<br />
ritamtavares@gmail.com<br />
88
Rita Teodoro<br />
Harvard Medical School, USA<br />
roteodoro@yahoo.com<br />
Rui Goncalo Martinho<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
rmartinho@igc.gulbenkian.pt<br />
Rui Peixoto<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />
rmartinho@igc.gulbenkian.pt<br />
Severina Moreira<br />
University of Bristol, UK<br />
severina_moreira@hotmail.com<br />
Sheila Vidal<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
svidal@igc.gulbenkian.pt<br />
Silvia Costa<br />
ISPA, PT<br />
silviasantoscosta@gmail.com<br />
89
Sofia Araujo<br />
IBMB-CSIC, SPAIN<br />
sofia.araujo@irbbarcelona.org<br />
Sofia Braga<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
sbraga@igc.gulbenkian.pt<br />
Susana Vaz Nery<br />
CISA PROJECT, ANGOLA<br />
susana.nery@gmail.com<br />
Tiago Botelho<br />
IBMB-CSIC, SP<br />
tobcri@ibmb.csic.es<br />
Tiago Carneiro<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
tcarneir@igc.gulbenkian.pt<br />
Tiago Carvalho<br />
LabOr<strong>de</strong>rs, PT<br />
tiago@labor<strong>de</strong>rs.com<br />
90
Ulla-Maj Fiuza<br />
No instituition affiliation<br />
umfiuza@igc.gulbenkian.pt<br />
Vasco Barreto<br />
<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />
vbarreto@igc.gulbenkian.pt<br />
Vanessa Luis<br />
<strong>Instituto</strong> <strong>de</strong> Medicina Molecular, PT<br />
vluis@fm.ul.pt<br />
Vera Teixeira<br />
<strong>Instituto</strong> <strong>de</strong> Medicina Molecular, PT<br />
teixeira@igc.gulbenkian.pt<br />
91